<SEC-DOCUMENT>0001104659-21-055660.txt : 20210427
<SEC-HEADER>0001104659-21-055660.hdr.sgml : 20210427
<ACCEPTANCE-DATETIME>20210427165033
ACCESSION NUMBER:		0001104659-21-055660
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20210427
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210427
DATE AS OF CHANGE:		20210427

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HEALTHEQUITY, INC.
		CENTRAL INDEX KEY:			0001428336
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-BUSINESS SERVICES, NEC [7389]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0131

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36568
		FILM NUMBER:		21859663

	BUSINESS ADDRESS:	
		STREET 1:		15 WEST SCENIC POINTE DRIVE
		STREET 2:		SUITE 100
		CITY:			DRAPER
		STATE:			UT
		ZIP:			84020
		BUSINESS PHONE:		801-727-1000

	MAIL ADDRESS:	
		STREET 1:		15 WEST SCENIC POINTE DRIVE
		STREET 2:		SUITE 100
		CITY:			DRAPER
		STATE:			UT
		ZIP:			84020

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTHEQUITY INC
		DATE OF NAME CHANGE:	20080227
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2114113d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:hqy="http://healthequity.com/20210427">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_029_US%2DGAAP%2D2020 -->
<!-- Field: Set; Name: xdx; ID: xdx_035_hqy_healthequity.com_20210427 -->
<!-- Field: Set; Name: xdx; ID: xdx_046_20210427_20210427 -->
<!-- Field: Set; Name: xdx; ID: xdx_052_edei%2D%2DEntityCentralIndexKey_0001428336 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2021-04-27to2021-04-27" name="dei:EntityCentralIndexKey">0001428336</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-04-27to2021-04-27" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="hqy-20210427.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2021-04-27to2021-04-27">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-27</xbrli:startDate>
        <xbrli:endDate>2021-04-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>

<p style="font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM&#160;<span id="xdx_900_edei--DocumentType_c20210427__20210427_zDnUCXt9K0H1"><ix:nonNumeric contextRef="From2021-04-27to2021-04-27" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section&#160;13 or 15(d)&#160;of</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>The Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event
reported): <b><span id="xdx_90C_edei--DocumentPeriodEndDate_c20210427__20210427_zOE8tc00nurh"><ix:nonNumeric contextRef="From2021-04-27to2021-04-27" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">April 27, 2021</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td colspan="1" style="border-bottom: Black 1pt solid; font: bold 18pt Times New Roman, Times, Serif; text-align: center"><p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 18pt Times New Roman, Times, Serif"><b><span id="xdx_909_edei--EntityRegistrantName_c20210427__20210427_zmQB88KcSLHe"><ix:nonNumeric contextRef="From2021-04-27to2021-04-27" name="dei:EntityRegistrantName">HealthEquity, Inc.</ix:nonNumeric></span></b></span></p></td></tr>
<tr style="vertical-align: bottom">
    <td colspan="1" style="font: normal 18pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt"><b style="font-style: normal; font-weight: normal">(Exact
    name of registrant as specified in charter)</b></span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table border="0" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90D_edei--EntityIncorporationStateCountryCode_c20210427__20210427_zv6uKhMmUpX"><ix:nonNumeric contextRef="From2021-04-27to2021-04-27" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></span></td>
    <td style="padding-bottom: 1pt; vertical-align: bottom; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Commission File No. <span id="xdx_905_edei--EntityFileNumber_c20210427__20210427_zHWmSknHsD1d"><ix:nonNumeric contextRef="From2021-04-27to2021-04-27" name="dei:EntityFileNumber">001-36568</ix:nonNumeric></span></span></td>
    <td style="padding-bottom: 1pt; vertical-align: bottom; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90B_edei--EntityTaxIdentificationNumber_c20210427__20210427_zIZuLo9m5Osl"><ix:nonNumeric contextRef="From2021-04-27to2021-04-27" name="dei:EntityTaxIdentificationNumber">52-2383166</ix:nonNumeric></span></span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(State or Other Jurisdiction<br />
 of Incorporation)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Commission<br />
File Number)</p>
<span style="font: 10pt Times New Roman, Times, Serif"></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(IRS Employer<br /> Identification No.)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b><span id="xdx_909_edei--EntityAddressAddressLine1_c20210427__20210427_zmZCcyLD0Lqd"><ix:nonNumeric contextRef="From2021-04-27to2021-04-27" name="dei:EntityAddressAddressLine1">15 West Scenic Pointe Drive</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b><span id="xdx_905_edei--EntityAddressAddressLine2_c20210427__20210427_zSkyDFmMycBk"><ix:nonNumeric contextRef="From2021-04-27to2021-04-27" name="dei:EntityAddressAddressLine2">Suite&#160;100</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b><span id="xdx_901_edei--EntityAddressCityOrTown_c20210427__20210427_zZVLKDX3od3l"><ix:nonNumeric contextRef="From2021-04-27to2021-04-27" name="dei:EntityAddressCityOrTown">Draper</ix:nonNumeric></span>, <span id="xdx_90D_edei--EntityAddressStateOrProvince_c20210427__20210427_zT6yWYBGo9Xb"><ix:nonNumeric contextRef="From2021-04-27to2021-04-27" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Utah</ix:nonNumeric></span> <span id="xdx_904_edei--EntityAddressPostalZipCode_c20210427__20210427_zevWoo8NIHD5"><ix:nonNumeric contextRef="From2021-04-27to2021-04-27" name="dei:EntityAddressPostalZipCode">84020</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(Address of principal executive offices) (Zip Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>(<span id="xdx_90F_edei--CityAreaCode_c20210427__20210427_zjahKGaICCei"><ix:nonNumeric contextRef="From2021-04-27to2021-04-27" name="dei:CityAreaCode">801</ix:nonNumeric></span>) <span id="xdx_90B_edei--LocalPhoneNumber_c20210427__20210427_zFNo0PVpp7l9"><ix:nonNumeric contextRef="From2021-04-27to2021-04-27" name="dei:LocalPhoneNumber">727-1000</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(Registrant&#8217;s
telephone number, including area code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Not applicable</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed since last report.)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form&#160;8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<span style="text-decoration: underline">see</span> General Instruction A.2 below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span id="xdx_903_edei--WrittenCommunications_c20210427__20210427_zHxNaRofEjda" style="font-family: Wingdings"><ix:nonNumeric contextRef="From2021-04-27to2021-04-27" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></td><td style="text-align: justify">Written communications pursuant to Rule&#160;425 under
the Securities Act (17 CFR 230.425)</td>
</tr></table>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span id="xdx_90F_edei--SolicitingMaterial_c20210427__20210427_z4fRbX6uyj2k" style="font-family: Wingdings"><ix:nonNumeric contextRef="From2021-04-27to2021-04-27" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></td><td style="text-align: justify">Soliciting material pursuant to Rule&#160;14a-12 under
the Exchange Act (17 CFR 240.14a-12)</td>
</tr></table>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span id="xdx_904_edei--PreCommencementTenderOffer_c20210427__20210427_zfbHu9xrpZS4" style="font-family: Wingdings"><ix:nonNumeric contextRef="From2021-04-27to2021-04-27" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></td><td style="text-align: justify">Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under
the Exchange Act (17 CFR 240.14d-2(b))</td>
</tr></table>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span id="xdx_90A_edei--PreCommencementIssuerTenderOffer_c20210427__20210427_zkSHVok6rhTa" style="font-family: Wingdings"><ix:nonNumeric contextRef="From2021-04-27to2021-04-27" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></td><td style="text-align: justify">Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under
the Exchange Act (17 CFR 240.13e-4(c))</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section&#160;12(b)&#160;of
the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table border="0" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; width: 37%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Title&#160;of&#160;Each&#160;Class</b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 26%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Trading&#160;Symbol(s)</b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 33%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Name&#160;of&#160;each&#160;exchange&#160;on&#160;which<br />
&#160;registered</b></span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90D_edei--Security12bTitle_c20210427__20210427_zmlisd1hsiwl"><ix:nonNumeric contextRef="From2021-04-27to2021-04-27" name="dei:Security12bTitle">Common stock, par value $0.0001 per share</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90E_edei--TradingSymbol_c20210427__20210427_z9qSlJ4tOsUl"><ix:nonNumeric contextRef="From2021-04-27to2021-04-27" name="dei:TradingSymbol">HQY</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_900_edei--SecurityExchangeName_c20210427__20210427_zuIBtDuc4Lze"><ix:nonNumeric contextRef="From2021-04-27to2021-04-27" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The NASDAQ Global Select Market</ix:nonNumeric></span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="margin: 0pt 0; text-align: justify; text-indent: 0.5in; font-size: 10pt">Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="margin: 0pt 0; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="margin: 0pt 0; text-align: right; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;Emerging
growth company <span style="font-family: Wingdings"><span id="xdx_904_edei--EntityEmergingGrowthCompany_c20210427__20210427_zATsSeSKGhO2"><ix:nonNumeric contextRef="From2021-04-27to2021-04-27" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="margin: 0pt 0; text-align: justify; text-indent: 0.5in; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with
any new or revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act. <span style="font-family: Wingdings">&#168;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 1.01 Entry into a Material Definitive Agreement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">O<span style="background-color: White">n April&#160;27,
2021, HealthEquity,&#160;Inc., a Delaware corporation (&#8220;HealthEquity&#8221;), entered into a Custodial Transfer and Asset Purchase
Agreement (the &#8220;Purchase Agreement&#8221;) with Fifth Third Bank,</span> National Association, a national banking association (&#8220;Fifth
Third Bank&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Purchase Agreement contemplates a
transfer to HealthEquity of approximately 149,000 current HSA members and their approximately $477.0 million of HSA
assets. The Purchase Agreement provides that HealthEquity will, at the closing of the transactions contemplated thereby (the
&#8220;Closing&#8221;), pay an aggregate purchase price of $60.8 million (the &#8220;Purchase Price&#8221;), subject to a
post-Closing purchase price adjustment based on the amount of HSA assets actually transferred, as consideration for its acquisition
of the exclusive right to act as custodian of the HSA Accounts (as defined in the Purchase Agreement) and the assumption of certain
specified obligations. In addition, under the terms of the Purchase Agreement, Fifth Third Bank will transition its notional
accounts business (consisting of flexible spending accounts, health reimbursement arrangements and commuter accounts) to
HealthEquity (such acquisition of the exclusive right to act as custodian of the HSA Accounts and the transition of the notional
accounts, the &#8220;Acquisition&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Consummation of the Acquisition is subject to
satisfaction of certain conditions at the Closing, including, without limitation (i)&#160;the nonexistence of any governmental order prohibiting
the consummation of the Acquisition, (ii)&#160;receipt of certain regulatory approvals, (iii)&#160;HealthEquity and Fifth Third Bank entering
into a master services agreement in a form to be agreed between the parties prior to the Closing for the provision of health savings accounts
and notional accounts to Fifth Third Bank employees, and (iv)&#160; the execution and delivery of certain customary closing certificates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Purchase Agreement contains customary representations,
warranties and covenants for a transaction of this type, including representations and warranties by (a)&#160;Fifth Third Bank regarding,
among other things, (i)&#160;its corporate organization, (ii)&#160;its authority to enter into the Purchase Agreement and perform its
obligations thereunder, (iii)&#160;the absence of certain legal proceedings, (iv)&#160;compliance with law and (v)&#160;title, and (b)&#160;HealthEquity
regarding, among other things, its (i)&#160;corporate organization and (ii)&#160;its authority to enter into the Purchase Agreement and
perform its obligations thereunder. The Purchase Agreement also contains post-closing indemnification obligations subject to certain de
minimis, deductible and cap limitations and time limitations with respect to recovery for losses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Purchase Agreement contains certain customary
termination rights prior to the Closing for both HealthEquity and Fifth Third Bank.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In consideration of the Purchase Price, Fifth
Third Bank has agreed to a customary non-competition provision preventing Fifth Third Bank from participating in certain competitive activities,
including acting as trustee or custodian for health savings accounts in the United States or otherwise offering or administering health
savings accounts, flexible spending accounts, health reimbursement arrangements or commuter accounts in the United States for a period
of five years following the Closing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Purchase Agreement has been included to provide
investors with information regarding its terms. It is not intended to provide any other factual information about HealthEquity, Fifth
Third Bank or their respective subsidiaries or affiliates. The representations, warranties and covenants contained in the Purchase Agreement
were made only for purposes of the Purchase Agreement and as of specific dates, were solely for the benefit of the parties to the Purchase
Agreement, may be subject to limitations agreed upon by the contracting parties, including being qualified by confidential disclosures
made for the purposes of allocating contractual risk between the parties to the Purchase Agreement instead of establishing these matters
as facts, and may be subject to standards of materiality applicable to the contracting parties that differ from those applicable to investors.
Investors are not third-party beneficiaries under the Purchase Agreement and should not rely on the representations, warranties and covenants
or any descriptions thereof as characterizations of the actual state of facts or condition of the parties thereto or any of their respective
subsidiaries or affiliates. Moreover, information concerning the subject matter of representations and warranties may change after the
date hereof, which subsequent information may or may not be fully reflected in HealthEquity&#8217;s public disclosures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing description of the Purchase Agreement
does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Purchase Agreement, a copy of
which is filed as Exhibit&#160;2.1 and incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></span> -</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 7.01. Regulation FD Disclosure</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: White">On April&#160;27,
2021, HealthEquity issued a press release announcing that HealthEquity had entered into Purchase Agreement. A copy of HealthEquity&#8217;s
press release announcing the transaction is attached</span> hereto as Exhibit&#160;99.1 and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The information in this Item 7.01, including the
corresponding Exhibit&#160;99.1, is being furnished with the U.S. Securities and Exchange Commission (SEC) and shall not be deemed &#8220;filed&#8221;
for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration: underline">Cautionary Statement Regarding Forward-Looking Statements</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Form&#160;8-K and the exhibits attached hereto
and incorporated herein by reference contain &#8220;forward-looking statements&#8221; within the meaning of the &#8220;safe harbor&#8221;
provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding the proposed transaction
between HealthEquity and Fifth Third Bank and the timing of such proposed transaction. All statements other than statements of historical
fact that address activities, events or developments that HealthEquity expects, believes or anticipates will or may occur in the future
are forward-looking statements. Forward-looking statements reflect current expectations regarding future events, results or outcomes,
and are typically identified by words such as &#8220;will&#8221;, &#8220;shall&#8221; or similar expressions that convey the prospective
nature of events or outcomes. Factors that could cause actual results to differ include, but are not limited to: the conditions to the
completion of the proposed transaction, including <span style="background-color: white">the receipt of all required regulatory approvals;
</span>the ability of HealthEquity to successfully integrate the acquired assets into HealthEquity&#8217;s current business; that such
integration may be more difficult, time-consuming or costly than expected; and that operating costs, customer loss and business disruption
(including, without limitation, difficulties in maintaining relationships with customers or vendors) may be greater than expected following
the proposed transaction or the public announcement of the proposed transaction. Although HealthEquity believes the expectations reflected
in the forward-looking statements are reasonable, HealthEquity gives no assurance these expectations will prove to be correct. Actual
events, results and outcomes may differ materially from expectations due to a variety of known and unknown risks, uncertainties and other
factors, including those described above. For a detailed discussion of other risk factors, please refer to the risks detailed in HealthEquity&#8217;s
filings with the Securities and Exchange Commission, including, without limitation, HealthEquity's most recent Annual Report on Form&#160;10-K
and subsequent periodic and current reports. HealthEquity undertakes no intention or obligation to update or revise any forward-looking
statements, whether as a result of new information, future events or otherwise. Forward-looking statements should not be relied upon as
representing views as of any date subsequent to the date of this Form&#160;8-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 9.01 Financial Statements and Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b>(d)&#160;Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 72px; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Exhibit</b></span></td>
    <td style="width: 10px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Number</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Description</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><a href="tm2114113d1_ex2-1.htm" style="-sec-extract: exhibit"><span style="font: 10pt Times New Roman, Times, Serif">2.1</span></a></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: justify"><a href="tm2114113d1_ex2-1.htm" style="-sec-extract: exhibit"><span style="font: 10pt Times New Roman, Times, Serif">Custodial Transfer and
    Asset Purchase Agreement, dated as of </span><span style="font-family: Times New Roman, Times, Serif; background-color: White">April&#160;27,
    2021, by and between Fifth Third Bank, National Association, and HealthEquity,&#160;Inc.*</span></a></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><a href="tm2114113d1_ex99-1.htm" style="-sec-extract: exhibit"><span style="font: 10pt Times New Roman, Times, Serif">99.1</span></a></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: justify"><a href="tm2114113d1_ex99-1.htm" style="-sec-extract: exhibit"><span style="font: 10pt Times New Roman, Times, Serif">Press Release da<span style="background-color: White">ted
    April&#160;27, 2021.</span></span></a></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">104</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Cover Page&#160;Interactive
    Data File (formatted in Inline XBRL and contained in Exhibit&#160;101)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;* Schedules and exhibits have been omitted
pursuant to Item 601(b)(2)&#160;of Regulation&#160;S-K.&#160;HealthEquity hereby undertakes to furnish supplementally copies of any of
the omitted schedules upon request by the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></span> -</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Date<span style="background-color: White">d:
    April&#160;27, 2021</span></span></td>
    <td colspan="2" style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>HealthEquity,&#160;Inc.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; width: 50%; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; width: 4%"><span style="font: 10pt Times New Roman, Times, Serif">By:</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 46%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>/s/ Tyson Murdock</i></span></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Name: </span></td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Tyson Murdock</span></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Title:</span></td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Executive Vice President and Chief Financial Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjV0KwjAQhE/QOyx5LppWRO2jRUWsIkXE19huJdhmyyb+HclbGlvEZWFZZr4ZIUKxoqWukeE0zzM4YNPWyiHkWCGjKdA70vUmAX9zvGjrWBnXvT8wJc+gZ8YDeS680Fnv2mKZgJwMR9EwmoGcJnEM+60IvnpKptIlGqdVDcqUsGdqWaNT/OoTDupJhppXV3VEtppMAtFA9vIbYhnFsKO7ehBfLWRZKoKwm0CsmG7tt+ZmHTWwqLHxXbZH/xt8AD1TSYE= -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>tm2114113d1_ex2-1.htm
<DESCRIPTION>EXHIBIT 2.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">



<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 2.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Execution Version</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CUSTODIAL TRANSFER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AND</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSET PURCHASE AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>by and between</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FIFTH THIRD BANK, NATIONAL ASSOCIATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>and</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>HEALTHEQUITY,&nbsp;INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>dated as of April 27, 2021</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>TABLE OF CONTENTS<SUP></SUP></U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><U>Page</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">ARTICLE&nbsp;I DEFINITIONS</FONT></TD>
    <TD STYLE="text-align: right">1</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; width: 15%">&nbsp;</TD>
    <TD STYLE="width: 80%">&nbsp;</TD>
    <TD STYLE="text-align: right; width: 5%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;1.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitions</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">ARTICLE&nbsp;II SALE AND PURCHASE</FONT></TD>
    <TD STYLE="text-align: right">9</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sale and Purchase</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumed Liabilities</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excluded Liabilities</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.4</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchase Price</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.5</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Signing</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.6</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Post-Signing Deliverables</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.7</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Post-Conversion Purchase Price Adjustment</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">ARTICLE&nbsp;III REPRESENTATIONS AND WARRANTIES OF SELLER</FONT></TD>
    <TD STYLE="text-align: right">11</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Organization and Related Matters</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authority; No Violation</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consents and Approvals</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.4</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Material Contracts</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.5</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No Broker</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.6</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Absence of Defaults</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.7</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal Proceedings</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.8</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compliance with Applicable Law; Permits</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.9</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxes</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.10</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.11</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.12</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Data Privacy</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.13</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial Information</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.14</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Absence of Certain Changes</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.15</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bankruptcy and Solvency</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.16</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Limitations on Representations and Warranties</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">ARTICLE&nbsp;IV REPRESENTATIONS AND WARRANTIES OF BUYER</FONT></TD>
    <TD STYLE="text-align: right">16</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Organization and Related Matters</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authority; No Violation</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consents and Approvals</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.4</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal Proceedings</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.5</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No Broker</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.6</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financing</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.7</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Limitations on Representations and Warranties</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">ARTICLE&nbsp;V HSA CUSTODIAL TRANSFER MATTERS</FONT></TD>
    <TD STYLE="text-align: right">17</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; width: 15%">&nbsp;</TD>
    <TD STYLE="width: 80%">&nbsp;</TD>
    <TD STYLE="text-align: right; width: 5%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;5.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice of Resignation</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;5.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transition Period Operating Matters</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;5.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice Period Reporting</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;5.4</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Custodial Resignation</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;5.5</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment Asset Matters</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;5.6</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debit Card and Online Transaction Processing</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;5.7</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bulk Cash Assets Transfer</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;5.8</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recordkeeping Matters</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;5.9</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remittances</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;5.10</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Required Consents</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">ARTICLE&nbsp;VI NOTIONAL ACCOUNT TRANSITION</FONT></TD>
    <TD STYLE="text-align: right">19</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;6.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transition Period Operating Matters</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;6.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contractual Matters; Cooperation</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">ARTICLE&nbsp;VII OTHER AGREEMENTS</FONT></TD>
    <TD STYLE="text-align: right">20</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;7.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confidentiality and Announcements; Communications</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;7.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenses</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;7.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further Assurances; Wrong Pocket</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;7.4</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Competition</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;7.5</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee Matters</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">ARTICLE&nbsp;VIII TAX MATTERS</FONT></TD>
    <TD STYLE="text-align: right">23</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;8.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax Cooperation</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;8.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfer Taxes</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;8.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax Reporting</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-left: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">ARTICLE&nbsp;IX CONDITIONS TO CONVERSION</FONT></TD>
    <TD STYLE="text-align: right">24</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;9.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conditions to Obligations of Buyer</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;9.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conditions to Obligations of Seller</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-left: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">ARTICLE&nbsp;X TERMINATION</FONT></TD>
    <TD STYLE="text-align: right">26</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;10.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Termination of Agreement</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;10.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect of Termination</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">ARTICLE&nbsp;XI INDEMNIFICATION</FONT></TD>
    <TD STYLE="text-align: right">27</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;11.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Survival of Representations and Warranties and Agreements</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;11.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnification by Seller</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; width: 15%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;11.3</FONT></TD>
    <TD STYLE="width: 80%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnification by Buyer</FONT></TD>
    <TD STYLE="text-align: right; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;11.4</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnification Procedure</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;11.5</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain Damages; Certain Offsets; Calculation of Damages</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;11.6</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exclusive Remedy</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;11.7</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Treatment of Indemnification Payments</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">ARTICLE&nbsp;XII MISCELLANEOUS</FONT></TD>
    <TD STYLE="text-align: right">32</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;12.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendments; Waiver</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;12.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Entire Agreement</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;12.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interpretation</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;12.4</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Severability</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;12.5</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notices</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;12.6</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Binding Effect; Persons Benefiting; No Assignment</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;12.7</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Counterparts</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;12.8</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Waiver of Jury Trial</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;12.9</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Governing Law; Venue</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;12.10</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Specific Performance</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;12.11</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No Third-Party Beneficiary</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;12.12</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bulk Sales Waiver</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exhibit&nbsp;A</U></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Master Services Agreement Key Terms</FONT></TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Schedule 1</U></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller Disclosure Schedule</FONT></TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Schedule 2</U></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HSA Post-Conversion Services</FONT></TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CUSTODIAL TRANSFER AND ASSET PURCHASE AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">This CUSTODIAL TRANSFER AND ASSET PURCHASE AGREEMENT,
dated as of April 27, 2021 (this &ldquo;<B>Agreement</B>&rdquo;), is by and between Fifth Third Bank, National Association,
a national banking association (&ldquo;<B>Seller</B>&rdquo;), and HealthEquity,&nbsp;Inc., a Delaware corporation (&ldquo;<B>Buyer</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>W I T N E S S E T H:</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">WHEREAS, Seller acts as a qualified custodian (pursuant
to Section&nbsp;223 of the Internal Revenue Code of 1986, as amended (the &ldquo;<B>Code</B>&rdquo;)) for certain Health Savings Accounts
(as hereinafter defined), which Seller offers together with certain Flexible Spending Accounts, Health Reimbursement Arrangements and
Commuter Accounts (each as hereinafter defined);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">WHEREAS, the Flexible Spending Accounts, Health Reimbursement
Arrangements and Commuter Accounts offered by Seller are herein referred to as the &ldquo;<B>Notional Accounts</B>,&rdquo; and the Health
Savings Accounts for which Seller acts as qualified custodian, together with the Notional Accounts, are herein referred to as the &ldquo;<B>Account
Portfolio</B>;&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">WHEREAS, Seller is willing (i)&nbsp;to cease offering
the Account Portfolio and (ii)&nbsp;to resign as qualified custodian for the Health Savings Accounts contained therein, and in connection
therewith is willing to complete the Custodial Transfer (as hereinafter defined);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">WHEREAS, Buyer is willing to accept the Custodial
Transfer and desires to purchase and assume from Seller the Acquired Assets (as hereinafter defined) and the Assumed Liabilities (as hereinafter
defined), all as more fully described herein; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">WHEREAS, the parties desire to make certain representations,
warranties, covenants and agreements as provided in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">NOW, THEREFORE, in consideration of the foregoing
and the representations, warranties, covenants and agreements set forth herein, and for other good and valuable consideration, and intending
to be legally bound, the parties agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;I<BR>
DEFINITIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;1.1</FONT><FONT STYLE="color: #010000">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Definitions</U>.
For all purposes of this Agreement, the following terms shall have the respective meanings set forth in this <U>Section&nbsp;1.1</U>
(such definitions to be equally applicable to both the singular and plural forms of the terms herein defined):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Accounts</B>&rdquo; shall mean (i)&nbsp;all
of the Flexible Spending Accounts offered by Seller, (ii)&nbsp;all of the Health Reimbursement Arrangements offered by Seller, (iii)&nbsp;all
of the Health Savings Accounts, which may be comprised of a Deposit Account, an Investment Account or both, offered by Seller and for
which Seller serves as custodian, and (iv)&nbsp;all of the Commuter Accounts offered by Seller.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Account Agreements</B>&rdquo; shall mean
each agreement, including a custodial agreement (together, in each case, with all modifications, amendments, supplements or other changes
thereto), entered into between Seller and an Account Holder under which an Account is established and which contains the terms and conditions
applicable to the Account.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Account Assets</B>&rdquo; shall mean Cash
Assets together with Investment Assets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Account Files</B>&rdquo; shall mean the
following information in respect of the Accounts: (i)&nbsp;the demographic information used to process and service the Accounts, (ii)&nbsp;available
balance information, (iii)&nbsp;historical transaction information and (iv)&nbsp;information collected in accordance with Seller&rsquo;s
Customer Identification Program (CIP) procedures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Account Holder</B>&rdquo; shall mean a
Person in whose name an Account has been established, whether individually or pursuant to an arrangement with such Account Holder&rsquo;s
employer, and any authorized users of such Account.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Account Liabilities</B>&rdquo; shall mean
all deposit liabilities, including all Accrued Interest, with respect to the Accounts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Account Portfolio</B>&rdquo; shall have
the meaning set forth in the Recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Accrued Interest</B>&rdquo; shall mean,
as of any date, with respect to the Deposit Accounts, interest that has been accrued on but not paid to such Deposit Accounts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Acquired Assets</B>&rdquo; shall have the
meaning set forth in <U>Section&nbsp;2.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Adjustment Multiple</B>&rdquo; shall mean
0.1274509804.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Adjustment Statement</B>&rdquo; shall have
the meaning set forth in <U>Section&nbsp;2.7(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Affiliate</B>&rdquo; shall mean any individual,
partnership, corporation, entity or other Person that, directly or indirectly through one or more intermediaries, controls, is controlled
by or is under common control with the Person specified.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Agreed Claims</B>&rdquo; shall have the
meaning set forth in <U>Section&nbsp;11.4(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Agreement</B>&rdquo; shall have the meaning
set forth in the Preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Allocation Schedule</B>&rdquo; shall have
the meaning set forth in <U>Section&nbsp;2.5(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Applicable Law</B>&rdquo; shall mean any
domestic or foreign federal, state or local statute, law (whether statutory or common law), ordinance, rule, administrative interpretation
or regulation (including those of any Governmental Authority or self-regulatory organization), applicable to and legally binding on Buyer
or Seller or any of their respective Affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Assumed Liabilities</B>&rdquo; shall have
the meaning set forth in <U>Section&nbsp;2.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Audit Firm</B>&rdquo; shall have the meaning
set forth in <U>Section&nbsp;2.5(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Available Balance Report</B>&rdquo; shall
have the meaning set forth in <U>Section&nbsp;5.7</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Bulk Cash Assets Transfer</B>&rdquo; shall
have the meaning set forth in <U>Section&nbsp;5.7</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Business Day</B>&rdquo; shall mean any
day that is not a Saturday, a Sunday or a day on which banks in Salt Lake City, Utah are authorized or required to close for regular banking
business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Buyer</B>&rdquo; shall have the meaning
set forth in the Preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Buyer Fundamental Representations</B>&rdquo;
shall mean the representations and warranties of Buyer set forth in <U>Section&nbsp;4.1</U> (Organization and Related Matters), <U>Section&nbsp;4.2(a)</U>&nbsp;(Authority;
No Violation) and <U>Section&nbsp;4.5</U> (No Broker).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Buyer Indemnitees</B>&rdquo; shall have
the meaning set forth in <U>Section&nbsp;11.2(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Buyer Material Adverse Effect</B>&rdquo;
shall mean, with respect to Buyer, any circumstance, change, development, condition or event that, individually or in the aggregate, prevents,
or would be reasonably likely to prevent, Buyer from consummating the Transactions on a timely basis and fulfilling its obligations under
this Agreement, but in each case excluding any effect to the extent arising out of or resulting from (A)&nbsp;changes, after the date
hereof, in generally accepted accounting principles or regulatory accounting requirements applicable to banks or their holding companies
generally, (B)&nbsp;changes, after the date hereof, in laws, rules&nbsp;or regulations of general applicability or interpretations thereof
by courts or governmental agencies or authorities, (C)&nbsp;changes, after the date hereof, in global, national or regional political
conditions or in general U.S. national or regional or global economic or market conditions affecting banks or their holding companies
generally (including changes in interest or exchange rates or in credit availability and liquidity), (D)&nbsp;execution, announcement
or consummation of this Agreement and the transactions contemplated hereby, including the impact thereof on customers, suppliers, licensors,
employees and others having business relationships with the Buyer, (E)&nbsp;the commencement, occurrence, continuation or escalation of
any war, sabotage, armed hostilities or acts of terrorism, or (F)&nbsp;any acts of God, natural disasters, epidemic, pandemic or disease
outbreak (including the COVID-19 virus).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Cash Assets</B>&rdquo; shall mean any and
all cash held on deposit in a Deposit Account, or cash held in an Investment Account.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Claim Notice</B>&rdquo; shall have the
meaning set forth in <U>Section&nbsp;11.4(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Code</B>&rdquo; shall have the meaning
set forth in the Recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Commuter Account</B>&rdquo; shall mean
an account for a &ldquo;qualified transportation fringe&rdquo; benefit as defined in Section&nbsp;132(f)&nbsp;of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Confidentiality Agreement</B>&rdquo; shall
mean that certain Confidentiality Agreement, dated as of October&nbsp;18, 2020, by and between Seller and Buyer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Consent</B>&rdquo; of a Person shall mean
any consent, waiver, authorization, approval, concession, license, Permit, variance, exemption or Order of, registration, certificate,
declaration or filing with or report or notice to such Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Continuing Accounts</B>&rdquo; shall mean
the HSA Accounts for which Buyer shall have become custodian following the Custodial Transfer in accordance with the terms hereof. For
the avoidance of doubt, &ldquo;Continuing Accounts&rdquo; shall exclude any Accounts for which the Account Assets contained therein shall
not have been transferred to the custody of Buyer, in the cases of Accounts comprised of HSAs, whether as a result of objection by the
applicable Account Holder or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Contract</B>&rdquo; with respect to a Person
shall mean any contract, agreement, arrangement, commitment, undertaking, license or other instrument (including all amendments, modifications,
supplements or other changes thereto), whether written or oral, to which the applicable Person is a party or by which the applicable Person
or any of its properties or assets is bound.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Controlling Party</B>&rdquo; shall have
the meaning set forth in <U>Section&nbsp;11.4(d)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Conversion Date</B>&rdquo; shall mean
the date that is mutually agreeable to the Parties, but in no event less than thirty-one (31) calendar days after the date that the
last of the conditions set forth in Sections 9.1 and 9.2 are satisfied or duly waived, or such other date as may be mutually agreed
upon by Buyer and Seller.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Custodial Transfer</B>&rdquo; shall mean
the transfer from Seller to Buyer of custody of the Accounts that are HSAs, together with the transfer from Seller to Buyer (or its designee)
of the Account Assets held therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Custodian Resignation Letter</B>&rdquo;
shall have the meaning set forth in <U>Section&nbsp;5.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Damages</B>&rdquo; shall have the meaning
set forth in <U>Section&nbsp;11.2(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Data Protection Laws</B>&rdquo; shall have
the meaning set forth in <U>Section&nbsp;3.12(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>De Minimis Amount</B>&rdquo; shall have
the meaning set forth in <U>Section&nbsp;11.2(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Deposit Account</B>&rdquo; shall mean
deposit accounts, as such term is used in 12 U.S.C. 1813(1)(1), that are Health Savings Accounts, including Accrued Interest and
uncollected funds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Dispute Notice</B>&rdquo; shall have the
meaning set forth in <U>Section&nbsp;2.7(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Electronic Document</B>&rdquo; shall have
the meaning set forth in <U>Section&nbsp;12.7</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Employee</B>&rdquo; shall mean any current
or former officer, employee, individual consultant or other individual service provider of Seller or any of its Affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Enterprise Partner</B>&rdquo; shall mean
any Person with whom Seller or an Affiliate thereof is partnered through Contract to offer Accounts to individuals employed or enrolled
by such Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Excluded Liabilities</B>&rdquo; shall have
the meaning set forth in <U>Section&nbsp;2.3</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Excluded Taxes</B>&rdquo; shall mean any
Taxes of Seller or any Affiliate thereof relating to the Accounts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Flexible Spending Account</B>&rdquo; or
 &ldquo;<B>FSA</B>&rdquo; shall mean a &ldquo;flexible spending account&rdquo; as defined in Section&nbsp;125 of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Governmental Authority</B>&rdquo; shall
mean any United States or foreign government, any state or other political subdivision thereof, any entity exercising executive, legislative,
judicial, regulatory or administrative functions of or pertaining to government, including any authority, agency, department, board, commission
or instrumentality of the United States, any State of the United States or any political subdivision thereof or any foreign jurisdiction,
and any court, tribunal or arbitrator(s)&nbsp;of competent jurisdiction, which includes without limitation, the Office of the Comptroller
of the Currency and the Federal Deposit Insurance Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Health Savings Account</B>&rdquo; or &ldquo;<B>HSA</B>&rdquo;
shall mean a &ldquo;health savings account&rdquo; as defined in Section&nbsp;223 of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Health Reimbursement Arrangement</B>&rdquo;
or &ldquo;<B>HRA</B>&rdquo; shall mean a tax-advantaged employer-sponsored account used to reimburse employees for eligible medical expenses
as contemplated under Section&nbsp;213(d)&nbsp;of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; text-indent: 1in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B>HSA Account</B>&rdquo; shall mean an Account
that is a Health Savings Account, which may be comprised of a Deposit Account, an Investment Account or both, offered by Seller and for
which Seller serves as custodian.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; text-indent: 1in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<B>HSA Account Holder</B>&rdquo; means an
Account Holder in whose name an HSA Account has been established, whether individually or pursuant to an arrangement with such Account
Holder&rsquo;s employer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>HSA Notice Period</B>&rdquo; shall have
the meaning set forth in Section&nbsp;5.3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>HSA Transition Period</B>&rdquo; shall
have the meaning set forth in <U>Section&nbsp;5.2</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Indemnified Party</B>&rdquo; shall have
the meaning set forth in <U>Section&nbsp;11.4(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Indemnifying Party</B>&rdquo; shall have
the meaning set forth in <U>Section&nbsp;11.4(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Interfering Activities</B>&rdquo; shall
mean encouraging, soliciting or inducing any Person, including any health plan, employer, joint marketing partner, account holder or other
business relation, to cease doing business with, or reduce the amount of business conducted with Buyer, or in any way interfere with the
relationship between any such Person and Buyer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Investment Accounts</B>&rdquo; shall mean
HSA Accounts, other than Deposit Accounts, which include securities or other non-cash investments as directed by the Account Holder pursuant
to the terms of the Account Agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Investment Assets</B>&rdquo; shall mean
any and all non-cash investments (including mutual funds and money-market funds) held in an Investment Account.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Knowledge</B>&rdquo; (i)&nbsp;with respect
to Seller shall mean the knowledge, after reasonable inquiry, of Jamie Leonard, Jan Pynappel and Mark Robich and (ii)&nbsp;with respect
to Buyer shall mean the knowledge, after reasonable inquiry, of Jon Kessler, Tyson Murdock and Delano Ladd.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Liabilities</B>&rdquo; shall mean any and
all debts, liabilities, guarantees, assurances, commitments, costs, expenses, fees and obligations, whether accrued or not accrued, fixed,
known or unknown, absolute or contingent, asserted or unasserted, matured or unmatured, liquidated or unliquidated, due or to become due,
or determined or determinable, whenever or however arising (including whether arising out of any Contract or tort based on negligence,
strict liability, other Applicable Law or related to Taxes payable).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Lien</B>&rdquo; shall mean any lien, claim,
charge, option, encumbrance, mortgage, right of way, easement, encroachment, servitude, right of first option, right of first refusal,
pledge or security interest or other restriction of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Master Services Agreement</B>&rdquo;
shall mean a Master Services Agreement in a form mutually agreeable to Buyer and Seller for the provision of Health Savings
Accounts, Flexible Spending Accounts, Health Reimbursement Arrangements and Commuter Accounts to Seller&rsquo;s employees, to be
entered into by and between Buyer and Seller prior to the Conversion Date, which shall include the key terms attached hereto as <U>Exhibit&nbsp;A</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Material Contract</B>&rdquo; shall have
the meaning set forth in <U>Section&nbsp;3.4</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Material Permit</B>&rdquo; shall have the
meaning set forth in <U>Section&nbsp;3.8(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Maximum Amount</B>&rdquo; shall have the
meaning set forth in <U>Section&nbsp;11.2(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Non-Controlling Party</B>&rdquo; shall
have the meaning set forth in <U>Section&nbsp;11.4(d)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Notional Accounts</B>&rdquo; shall have
the meaning set forth in the Recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Notional Account Transition Period</B>&rdquo;
shall have the meaning set forth in <U>Section&nbsp;6.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Order</B>&rdquo; shall mean any order,
judgment, injunction, award, decree, writ or other legally enforceable requirement handed down, adopted or imposed by, including any consent
decree, settlement agreement or similar written agreement with, any Governmental Authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Permits</B>&rdquo; shall mean all municipal,
state and federal and other governmental permits, licenses, registrations, agreements, waivers and authorizations held or used by the
applicable Person in connection with its business and operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Person</B>&rdquo; shall mean any individual,
corporation, company, partnership (limited or general), limited liability company, joint venture, association, estate, trust or other
business entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Personal Data</B>&rdquo; shall have the
same meaning as the term &ldquo;personal data,&rdquo; &ldquo;personal information,&rdquo; or the equivalent under applicable Data Protection
Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Plan Year End</B>&rdquo; shall mean the
conclusion of the benefit plan year, including any run-out or grace periods, as provided in an Enterprise Partner plan document (whether
or not corresponding to calendar year end) in which benefits associated with Notional Accounts are provided to Seller&rsquo;s Enterprise
Partners.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Proceedings</B>&rdquo; shall have the meaning
set forth in <U>Section&nbsp;3.7</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Purchase Price</B>&rdquo; shall have the
meaning set forth in <U>Section&nbsp;2.4</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Required Consent</B>&rdquo; shall mean
the approval, non-objection or similar decision or determination with respect to the consummation of the Transactions by any Governmental
Authority required by Applicable Law or any Order.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Resignation Notice Date</B>&rdquo; shall
have the meaning set forth in <U>Section&nbsp;5.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&ldquo;Restricted
Period</B></FONT>&rdquo; shall mean the period commencing on the Conversion Date and ending on the fifth (5th) anniversary of the Conversion
Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Seller</B>&rdquo; shall have the meaning
set forth in the Preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Seller Disclosure Schedule</B>&rdquo; shall
mean the disclosure schedule dated as of the date of this Agreement and delivered by Seller to Buyer prior to the execution and delivery
of this Agreement attached hereto as <U>Schedule 1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Seller Fundamental Representations</B>&rdquo;
shall mean the representations and warranties of Seller set forth in <U>Section&nbsp;3.1</U> (Organization and Related Matters), <U>Section&nbsp;3.2(a)</U>&nbsp;(Authority;
No Violation), <U>Section&nbsp;3.5</U> (No Broker), <U>Section&nbsp;3.10</U> (Title) and <U>Section&nbsp;3.15</U> (Bankruptcy and Solvency).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Seller Indemnitees</B>&rdquo; shall have
the meaning set forth in <U>Section&nbsp;11.3(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Seller Material Adverse Effect</B>&rdquo;
shall mean any circumstance, change, development, condition or event that, individually or in the aggregate, (a)&nbsp;has or would be
reasonably likely to have a material adverse effect on the Accounts, the Account Assets or the Acquired Assets, in each case taken as
a whole, or (b)&nbsp;that prevents, or would be reasonably likely to prevent, Seller and/or its applicable Affiliates from consummating
the Transactions on a timely basis and fulfilling its or their material obligations under this Agreement, but in each case excluding any
effect to the extent arising out of or resulting from (A)&nbsp;changes, after the date hereof, in generally accepted accounting principles
or regulatory accounting requirements applicable to banks or their holding companies generally, (B)&nbsp;changes, after the date hereof,
in laws, rules&nbsp;or regulations of general applicability or interpretations thereof by courts or governmental agencies or authorities,
(C)&nbsp;changes, after the date hereof, in global, national or regional political conditions or in general U.S. national or regional
or global economic or market conditions affecting banks or their holding companies generally (including changes in interest or exchange
rates or in credit availability and liquidity), (D)&nbsp;execution, announcement or consummation of this Agreement and the transactions
contemplated hereby, including the impact thereof on customers, suppliers, licensors, employees and others having business relationships
with the Seller, (E)&nbsp;the commencement, occurrence, continuation or escalation of any war, sabotage, armed hostilities or acts of
terrorism, or (F)&nbsp;any acts of God, natural disasters, epidemic, pandemic or disease outbreak (including the COVID-19 virus)..</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Split-Segment; Name: 2 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Signing Date</B>&rdquo; shall mean the
date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Straddle Period</B>&rdquo; shall mean
any taxable period beginning on or prior to and ending after the Conversion Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Survival Period</B>&rdquo; shall have
the meaning set forth in <U>Section&nbsp;11.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Target Cash Assets Amount</B>&rdquo; shall
mean Four Hundred Seventy-Six Million Nine Hundred Sixty-Three Thousand Seven Hundred Forty-Five Dollars ($476,963,745.00).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Tax Claim</B>&rdquo; shall have the meaning
set forth in <U>Section&nbsp;11.4(d)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Tax Return</B>&rdquo; shall mean all returns,
elections, claims for refund, declarations, reports, statements, estimates, information statements and other forms and documents (including
all schedules, supplements, exhibits and other attachments thereto) with respect to the calculation, determination, assessment or collection
of any Taxes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Taxes</B>&rdquo; shall mean all federal,
state, local or foreign net income, alternative or add-on minimum tax, gross income, gross receipts, sales, use, ad valorem, value added,
escheat, abandoned or unclaimed property, transfer, franchise, profits, license, withholding, payroll, employment, excise, severance,
stamp, occupation, premium, property, environmental or windfall profit tax, custom, duty or other tax or other like assessment of any
kind whatsoever, together with any interest, penalty, addition to tax or additional amount imposed by any Applicable Law or Taxing Authority,
whether disputed or not. For purposes of this Agreement, in the case of any Straddle Period, Taxes for any Tax period (or portion thereof)
ending on or before the Conversion Date shall be computed as if such taxable period ended as of the close of business on the Conversion
Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Taxing Authority</B>&rdquo; shall mean
any Governmental Authority having jurisdiction over the assessment, determination, collection or other imposition of any Tax.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Threshold Amount</B>&rdquo; shall have
the meaning set forth in <U>Section&nbsp;11.2(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Transactions</B>&rdquo; shall mean the
transactions contemplated by this Agreement including, for the avoidance of doubt, the transfer from Seller and its Affiliates to Buyer
of the exclusive right to act as trustee and custodian and administrator, as the case may be, of the Accounts (including all Account
Assets contained therein) and the right of Buyer to effect the Custodial Transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Transfer Taxes</B>&rdquo; shall have the
meaning set forth in <U>Section&nbsp;8.2</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Transferred Cash Assets Amount</B>&rdquo;
shall have the meaning set forth in <U>Section&nbsp;2.7(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Transitioned Enterprise Partner</B>&rdquo;
an Enterprise Partner who, during the HSA Transition Period, terminates its HSA relationship with Seller and establishes an HSA relationship
with Buyer or any Affiliate of Buyer and/or enrolls in Buyer&rsquo;s (or any of its Affiliate&rsquo;s) HSA offerings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Transitioned Enterprise Partner Cash Assets
Amount</B>&rdquo; means the amount of Cash Assets in Accounts of HSA Account Holders who are employed by a Transitioned Enterprise Partner
that are actually transferred from Seller to Buyer (or its designee) prior to (but not as part of) the Bulk Cash Assets Transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<B>Wire Transfer</B>&rdquo; shall mean a
payment in immediately available funds by wire transfer in lawful money of the United States to such account or to a number of accounts
as shall have been designated by written notice from the receiving party to the paying party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;II<BR>
SALE AND PURCHASE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;2.1</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Sale
and Purchase</U>. On the terms and subject to the conditions of this Agreement, on the Conversion Date, Seller shall sell, transfer,
assign, convey and deliver to Buyer, and Buyer shall purchase and acquire from Seller, in each case free and clear of all Liens, the
exclusive right (a)&nbsp;to act as custodian of the HSA Accounts, effective as of the Conversion Date, and (b)&nbsp;to effect the Custodial
Transfer on the Conversion Date (collectively, the &ldquo;<B>Acquired Assets</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;2.2</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Assumed
Liabilities</U>. On the terms and subject to the conditions of this Agreement, on the Conversion Date, Buyer will assume and agree to
pay, perform, be responsible for and discharge only the following Liabilities (collectively, the &ldquo;<B>Assumed Liabilities</B>&rdquo;):
All Liabilities arising immediately following the Custodial Transfer solely in respect of the Continuing Accounts comprised of HSAs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;2.3</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Excluded
Liabilities</U>. Buyer will not assume or be liable for any Liabilities of Seller or any of its Affiliates other than the Assumed Liabilities
(collectively, the &ldquo;<B>Excluded Liabilities</B>&rdquo;). Without limiting the generality of the foregoing, Buyer will not assume
or be liable for any of the following Liabilities, which shall constitute &ldquo;Excluded Liabilities&rdquo; hereunder: (a)&nbsp;the
Account Liabilities; (b)&nbsp;Excluded Taxes; (c)&nbsp;Liabilities arising under any Contracts of Seller or its Affiliates, whether relating
to the Accounts or otherwise, whenever incurred or accrued; (d)&nbsp;Liabilities of whatever kind and nature assessed in any Proceeding
to the extent relating to the Accounts or the Account Assets prior to or in connection with the Transactions, including the Custodial
Transfer; (e)&nbsp;Liabilities relating to any breach or alleged breach of the Account Agreements in connection with the Transactions
(including, for the avoidance of doubt, the Custodial Transfer); (f)&nbsp;Liabilities relating to any Employees of Seller or its Affiliates;
(g)&nbsp;any Liability relating to the Notional Accounts arising on or prior to the Plan Year End applicable to such Notional Accounts;
(h)&nbsp;any Liability for which Buyer has a right to indemnification pursuant to <U>Section&nbsp;11.2</U>, and (i)&nbsp;any Liability
of Seller relating to a Deposit Account.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;2.4</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Purchase
Price</U>. The &ldquo;<B>Purchase Price</B>&rdquo; for the Acquired Assets shall be an amount in cash equal to sixty million seven hundred
eighty-nine thousand four hundred ninety-six U.S. dollars and ninety-two U.S. cents ($60,789,496.92) (the &ldquo;<B>Purchase Price</B>&rdquo;),
which shall be paid by Buyer on the Conversion Date by Wire Transfer and shall be subject to adjustment as set forth in <U>Section&nbsp;2.7</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;2.5</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>The
Signing</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(a)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">On
the terms and subject to the conditions of this Agreement, the signing of this Agreement (the &ldquo;<B>Signing</B>&rdquo;) shall take
place on the date hereof remotely via the electronic exchange of documents (by facsimile, .pdf, e-mail or other form of electronic communication).
At the Signing each party shall deliver to the other: (i)&nbsp;duly executed counterparts to this Agreement and (ii)&nbsp;any other customary
certificates or other instruments as may reasonably be requested in order to give effect to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Value: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(b)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Buyer
and Seller agree that the Purchase Price shall be allocated among the Acquired Assets for all purposes (including Tax and financial accounting)
as shown on the allocation schedule (the &ldquo;<B>Allocation Schedule</B>&rdquo;). A draft of the Allocation Schedule shall be prepared
by Buyer and delivered to Seller within sixty (60) calendar days following the Conversion Date. If Seller notifies Buyer in writing within
ten (10)&nbsp;Business Days of receipt of the Allocation Schedule that Seller objects to one or more items reflected in the Allocation
Schedule, Seller and Buyer shall negotiate in good faith to resolve such dispute; provided, however, that if Seller and Buyer are unable
to resolve any dispute with respect to the Allocation Schedule within ninety (90) calendar days following the Conversion Date, such dispute
shall be resolved by a nationally recognized independent accountant mutually acceptable to Seller and Buyer (&ldquo;Audit Firm&rdquo;).
The fees and expenses of the Audit Firm will be borne equally by Seller and Buyer. If Seller does not object to the Allocation Schedule
within such ten (10)&nbsp;Business Day period, the Allocation Schedule will be final, binding and non-appealable by the parties. Buyer
and Seller shall file all Tax Returns (including amended returns and claims for refund) and information reports in a manner consistent
with the Allocation Schedule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;2.6</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Post-Signing
Deliverables</U>. After the Signing and prior to the Conversion Date, Seller and Buyer will enter into the Master Services Agreement.
Additionally, after the Signing and Prior to the Conversion Date, Seller and Buyer agree to discuss terms of and attempt to enter into
a mutually acceptable referral arrangement and fee structure for Seller&rsquo;s referral to Buyer of commercial customers for the provision
of HSA, HRA, FSA and Commuter Account services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;2.7</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Post-Conversion
Purchase Price Adjustment</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Promptly following the Conversion Date, but in any event no later than thirty (30) days thereafter, Seller shall prepare
and deliver to Buyer a statement (the &ldquo;<B>Adjustment Statement</B>&rdquo;) setting forth Seller&rsquo;s good faith calculation of
(i) the aggregate amount of Cash Assets (expressed in U.S. dollars) actually transferred from Seller to Buyer in the Bulk Cash Assets
Transfer and (ii) the aggregate amount of the Transitioned Enterprise Partner Cash Assets Amount (collectively, the &ldquo;<B>Transferred
Cash Assets Amount</B>&rdquo;). The Adjustment Statement shall be accompanied by all relevant backup materials and schedules relating
to the calculation of the Transferred Cash Assets Amount in detail reasonably acceptable to Buyer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(b)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">In
the event that Buyer disputes the calculation of the Transferred Cash Assets Amount set forth in the Adjustment Statement, Buyer shall
notify Seller in writing (the &ldquo;<B>Dispute Notice</B>&rdquo;) of the amount, nature and basis of such dispute within ten (10)&nbsp;Business
Days after delivery of the Adjustment Statement. In the event of such a dispute, Seller and Buyer shall first use their diligent good
faith efforts to resolve such dispute among themselves. If Seller and Buyer are unable to resolve the dispute within thirty (30) calendar
days after delivery of the Dispute Notice, then any remaining items in dispute shall be submitted to the Audit Firm.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(c)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">If
any dispute is submitted to the Audit Firm, each party will furnish to the Audit Firm such work papers and other documents and information
relating to the disputed issues as the Audit Firm may reasonably request and are available to that party. Each party shall be afforded
the opportunity to present to the Audit Firm material relating to the determination and to discuss the determination with the Audit Firm
at a meeting with all parties present. The Audit Firm shall not attribute a value to any disputed amount greater than the greatest amount
proposed by either party or an amount less than the least amount proposed by either party. The written decision of the Audit Firm shall
be rendered within no more than sixty (60) days from the date that the matter is referred to such firm and shall be final and binding
on the parties and, in the absence of fraud or manifest error, shall not be subject to dispute or review. Following any such dispute
resolution (whether by mutual agreement of the parties or by written decision of the Audit Firm), the calculation of the Transferred
Cash Assets Amount shall be determined final. The costs and expenses of the Audit Firm shall be allocated by the Audit Firm between Buyer,
on the one hand, and Seller, on the other hand, equally.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(d)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">If
the Transferred Cash Assets Amount is less than the Target Cash Assets Amount, then Seller shall, promptly after the final determination
of the Transferred Cash Assets Amount pursuant to this <U>Section&nbsp;2.7</U>, and in any event within three (3)&nbsp;Business Days
thereof, refund by Wire Transfer to Buyer an amount in cash equal to the Adjustment Multiple multiplied by the dollar value of such shortfall
amount. If the Transferred Cash Assets Amount is greater than the Target Cash Assets Amount, then Buyer shall, promptly after the final
determination of the Transferred Cash Assets Amount pursuant to this <U>Section&nbsp;2.7</U>, and in any event within three (3)&nbsp;Business
Days thereof, pay by Wire Transfer to Seller an amount in cash equal to the Adjustment Multiple multiplied by the dollar value of such
excess amount. All amounts paid pursuant to this <U>Section&nbsp;2.7(d)</U>&nbsp;shall be deemed to be an adjustment to the Purchase
Price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(e)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">In
the event that Seller fails to deliver timely an Adjustment Statement in accordance with <U>Section&nbsp;2.7(a)</U>&nbsp;above, no later
than forty-five (45) days following the Conversion Date, Buyer shall deliver to Seller an Adjustment Statement prepared in good faith
by Buyer setting forth Buyer&rsquo;s calculation of the Transferred Cash Assets Amount, which statement shall be conclusive and binding
on the parties upon delivery to Seller. Following delivery of the Adjustment Statement in accordance with this <U>Section&nbsp;2.7(e)</U>,
the Purchase Price shall be adjusted and refunded or paid, as applicable, in accordance with <U>Section&nbsp;2.7(d)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;III<BR>
REPRESENTATIONS AND WARRANTIES OF SELLER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">Except as set forth in the Seller Disclosure Schedule
(it being agreed that disclosure in any section of the Seller Disclosure Schedule shall apply to the indicated section of this Agreement
and to all other sections of this Agreement to the extent that it is readily apparent from such disclosure that such matter is relevant
to such other sections). Seller hereby represents and warrants as of the Signing Date and the Conversion Date (except to the extent made
only as of a specified date, in which case as of such date) to Buyer as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;3.1</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Organization
and Related Matters</U>. Seller is a duly organized and validly existing national banking association. Seller is duly qualified under
the Code (including Section&nbsp;223(d)(1)(B)&nbsp;thereof) and all other Applicable Law to serve as a custodian with respect to each
Health Savings Account and has the organizational power and authority to serve as custodian or administrator, as the case may be, for
the Accounts, to effect the Custodial Transfer and to own the Acquired Assets as and in the places where now administered or owned, as
the case may be. Seller is duly licensed or qualified to do business in each jurisdiction in which the nature of the business conducted
by it with respect to the Account Portfolio makes such licensing or qualification necessary, except where the failure to be so licensed
or qualified would not reasonably be expected to have, individually or in the aggregate, a Seller Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 4; Value: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;3.2</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Authority;
No Violation</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(a)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Seller
has all requisite corporate power and authority to execute and deliver this Agreement and to consummate the Transactions. The execution
and delivery of this Agreement and the consummation of the Transactions have been duly and validly approved by all necessary corporate
action on the part of Seller. No other corporate proceeding on the part of Seller or its Affiliates is necessary to approve this Agreement
or to consummate the Transactions. This Agreement have been duly and validly executed and delivered by Seller and its Affiliates, as
applicable, and, assuming due authorization, execution and delivery by Buyer, this Agreement constitute a valid and binding obligation
of Seller and its Affiliates, as applicable, enforceable against Seller and its Affiliates in accordance with its terms, except as such
enforcement may be limited by (i)&nbsp;the effect of bankruptcy, insolvency, reorganization, receivership, conservatorship, arrangement,
moratorium or other laws affecting or relating to the rights of creditors generally or (ii)&nbsp;the rules&nbsp;governing the availability
of specific performance, injunctive relief or other equitable remedies and general principles of equity, regardless of whether considered
in a proceeding in equity or at law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(b)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Neither
the execution and delivery of this Agreement by Seller or its Affiliates, nor the consummation by Seller or its Affiliates of the Transactions
nor compliance by Seller or its Affiliates with any of the terms or provisions hereof does or will (i)&nbsp;violate any provision of
the certificate of incorporation, bylaws, or similar organization documents of Seller or its Affiliates, or (ii)&nbsp;assuming that the
consents and approvals referred to in <U>Section&nbsp;3.3</U> are duly obtained, (A)&nbsp;violate any Applicable Law or (B)&nbsp;violate,
conflict with, result in a breach of any provision of or the loss of any benefit under, constitute a default (or an event which, with
notice or lapse of time, or both, would constitute a default) under, result in the termination of or a right of termination or cancellation
under or in any payment conditioned, in whole or in part, on consummation of the Transactions, accelerate the performance required by
or rights or obligations under, or result in the creation of any Lien upon any of the Acquired Assets under any of the terms, conditions
or provisions of any Contract to which Seller or any Affiliate thereof is a party relating to the Acquired Assets or Account Assets,
or by which the Acquired Assets or Account Assets may be bound or affected, except (in the case of this clause&nbsp;(ii)(B)) for such
violations, conflicts, breaches, defaults or loss of benefits which would not reasonably be expected to be material to the ongoing custody
and administration of the Accounts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;3.3</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Consents
and Approvals</U>. Except as set forth on <U>Section&nbsp;3.3</U> of the Seller Disclosure Schedule, Seller is not required to obtain
any Consent of, or provide notice to, any Governmental Authority or other Person in connection with (i)&nbsp;the execution and delivery
by Seller or its Affiliates, as applicable, of this Agreement or (ii)&nbsp;the consummation by Seller or its Affiliates, as applicable,
of the Transactions (including, for the avoidance of doubt, the Custodial Transfer and the liquidation of Investment Assets included
in the Custodial Transfer).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;3.4</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Material
Contracts</U>. Except with respect to the Contracts of Seller with the Enterprise Partners set forth on <U>Section&nbsp;3.4</U> of the
Seller Disclosure Schedule, Seller has provided Buyer with true, correct and complete copies of each Account Agreement and each other
Contract for each of the top 10 Enterprise Partners by number of HSA Accounts (each, a &ldquo;<B>Material Contract</B>&rdquo;). Each
Material Contract is valid, binding and in full force and effect. Seller is not in material breach under any of the Material Contracts,
and no event has occurred that, through the passage of time or the giving of notice, or both, would constitute a material breach by Seller
or give rise to a right of termination or cancellation by any counterparty of any of the Material Contracts. To Seller&rsquo;s Knowledge,
no other Person is in material breach under any of the Material Contracts, and no event has occurred which, with due notice or lapse
of time or both, would constitute such a material breach.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;3.5</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>No
Broker</U>. Neither Seller nor any Affiliate of Seller has employed any broker or finder or incurred any Liability for any broker&rsquo;s
fees, commissions or finder&rsquo;s fees in connection with this Agreement or the Transactions (other than any broker or finder whose
broker&rsquo;s fees, commissions or finder&rsquo;s fees shall be paid solely by Seller or its Affiliates).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;3.6</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Absence
of Defaults</U>. Seller is not in material default under or in material violation of (a)&nbsp;any Contract or other instrument, arrangement
of understanding to which Seller is a party and by which the Accounts or Account Assets are bound or affected, and to Seller&rsquo;s
Knowledge no fact, circumstance or event has occurred which, upon notice, lapse of time, or both, would constitute such a material default
or material violation; (b)&nbsp;any Applicable Law affecting the Accounts or Account Assets; or (c)&nbsp;any Order by which the Accounts
or Account Assets are bound or affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;3.7</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Legal
Proceedings</U>. There are no legal, administrative, arbitral or other proceedings, claims, suits, actions or governmental or regulatory
investigations or inquiries of any nature (collectively, &ldquo;<B>Proceedings</B>&rdquo;) that are pending or, to Seller&rsquo;s Knowledge,
threatened against or relating to Seller in connection with the administration of the Accounts or the custody of the Account Assets that
(a)&nbsp;would reasonably be expected to have, individually or in the aggregate, a Seller Material Adverse Effect or (b)&nbsp;would result,
or reasonably be expected to result, in any Liability that would be material to the administration of the Continuing Accounts or the
ownership of the Acquired Assets, except for any of the foregoing the contents or existence of which are subject to confidentiality restrictions
applicable to &ldquo;confidential supervisory information&rdquo; or &ldquo;non-public OCC information&rdquo; arising under Applicable
Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;3.8</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Compliance
with Applicable Law; Permits</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(a)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Since
January&nbsp;1, 2018, Seller has administered the Accounts in accordance in all material respects with Applicable Law, including the
Customer Identification Program provisions of Section&nbsp;326 of the U.S.A. Patriot Act of 2001, and is not in material default or material
violation of any such Applicable Law. Seller has not received any communication since January&nbsp;1, 2018 from a Governmental Authority
that alleges that Seller or any of its Affiliates is not in material compliance with any Applicable Law in connection with the custodial
administration of the Accounts or the custody of the Account Assets, except for any of the foregoing the contents or existence of which
are subject to confidentiality restrictions applicable to &ldquo;confidential supervisory information&rdquo; or &ldquo;non-public OCC
information&rdquo; arising under Applicable Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(b)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Seller
holds, owns or possesses all Permit necessary for the lawful administration of the Accounts or the custody of the Account Assets by Seller
as of the date hereof (each, a &ldquo;<B>Material Permit</B>&rdquo;) and is in compliance with its obligations under such Material Permits
in all material respects. Since January&nbsp;1, 2018, none of such Material Permits has been challenged or revoked in any material respect
and no statement of intention to challenge, revoke or fail to renew in any material respect any such Material Permit has been received
in writing by Seller or any Affiliate thereof, except for any of the foregoing the contents or existence of which are subject to confidentiality
restrictions applicable to &ldquo;confidential supervisory information&rdquo; or &ldquo;non-public OCC information&rdquo; arising under
Applicable Law..</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;3.9</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Taxes</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(a)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Seller
or an Affiliate thereof has timely paid all material Taxes that relate to the Accounts or any of the Acquired Assets that will have been
required to have been paid on or prior to the Conversion Date the nonpayment of which could (i)&nbsp;result in a lien for Taxes on the
Account Assets or any of the Acquired Assets, (ii)&nbsp;result in Buyer becoming liable or responsible therefor or (iii)&nbsp;have a
material adverse effect on Buyer&rsquo;s ability to administer the Continuing Accounts or own the Acquired Assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(b)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">None
of the Acquired Assets are &ldquo;tax exempt use property&rdquo; within the meaning of Section&nbsp;168(h)&nbsp;and Section&nbsp;470(c)(2)&nbsp;of
the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(c)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Seller
is not a &ldquo;foreign person&rdquo; within the meaning of Section&nbsp;1445 of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;3.10</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Title</U>.
Seller is the lawful owner of each of the Acquired Assets, free and clear of all Liens. Assuming the accuracy of Buyer&rsquo;s representations
and warranties and compliance with covenants set forth herein, on the Conversion Date, Seller will transfer to Buyer good and valid title
in and to all of the Acquired Assets, free and clear of all Liens.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;3.11</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Accounts</U>.
All of the Accounts have been administered and originated in compliance in all material respects with the documents governing the Accounts
(including all applicable Account Agreements) and all Applicable Law. There are no Accounts that are subject to any Proceeding that would
prohibit or impair in any material respect the ability of Seller or any Affiliate thereof to consummate the Transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;3.12</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Data
Privacy</U>. With respect to any Personal Data collected, stored, used, disclosed, transferred, or otherwise processed by Seller or any
Affiliate thereof in connection with the Accounts and Account Files:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(a)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">since
January&nbsp;1, 2018, Seller and each of its respective Affiliates has, in all material respects, complied with the terms of its own
published, posted, and internal agreements and policies in respect of data protection, data privacy and data security laws applicable
to Seller and its Affiliates, including, the Health Insurance Portability and Accountability Act, as amended, and all regulations implemented
thereunder (&ldquo;<B>Data Protection Laws</B>&rdquo;), with respect to (1)&nbsp;the collection, use, disclosure, and protection of Personal
Data and (2)&nbsp;the sending of solicited or unsolicited electronic marketing communications;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(b)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">since
January&nbsp;1, 2018, no material notice of a material Proceeding of any kind has been served on, and no material Proceeding has been
initiated against, Seller or any Affiliate thereof in respect of the Accounts or Account Files under any applicable Data Protection Law;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(c)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">there
are no pending or, to Seller&rsquo;s Knowledge, threatened Proceedings, fines, or other penalties against Seller or any Affiliate thereof
in connection with any material data security breaches relating to the Accounts or the Acquired Assets; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(d)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">to
Seller&rsquo;s Knowledge, since January&nbsp;1, 2018, neither Seller nor any of its Affiliates has experienced any material security
breaches of Personal Data related to the Accounts or the Acquired Assets that would require law enforcement or individual notification
or remedial action under any applicable Data Protection Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;3.13</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Financial
Information</U>. As of April 21, 2021, the Accounts comprised of HSAs consist of at least 149,298 HSAs that collectively contain at least
$476,963,745 in Account Assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;3.14</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Absence
of Certain Changes</U>. Except as set forth on <U>Section&nbsp;3.14</U> of the Seller Disclosure Schedule, since December&nbsp;31, 2020,
except as contemplated by this Agreement, (a)&nbsp;Seller has administered the Accounts in all material respects in the ordinary course
consistent with past practice and (b)&nbsp;there has not occurred, nor has any event or circumstance occurred that would have, or would
reasonably be expected to have, individually or in the aggregate, a Seller Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;3.15</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Bankruptcy
and Solvency</U>. Seller is not involved in any Proceeding by or against it as a debtor before any Governmental Authority under title
11 of the United States Bankruptcy Code or any other insolvency or debtors&rsquo; relief act or Applicable Law or for the appointment
of a trustee, receiver, liquidator, assignee, sequestrator or other similar official for any part of the Acquired Assets. Seller is not,
and after giving effect to the consummation of the Transactions will not be, &ldquo;insolvent&rdquo; within the meaning of Section&nbsp;101(32)
of title 11 of the United States Code or any applicable state fraudulent conveyance or transfer law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;3.16</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Limitations
on Representations and Warranties</U>. Except for the representations and warranties expressly set forth in this Agreement and in any
document delivered pursuant hereto, neither Seller nor any Affiliate of Seller nor any of their respective officers, directors, employees,
agents or representatives, nor any other Person, makes or shall be deemed to make any representation or warranty to Buyer, express or
implied, at law or in equity, written or oral, with respect to the Transactions, and Seller hereby disclaims any such representation
or warranty whether by Seller or any Affiliate of Seller or any of their respective officers, directors, employees, agents or representatives,
or any other Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;IV<BR>
REPRESENTATIONS AND WARRANTIES OF BUYER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">Buyer hereby represents and warrants as of the Signing
Date and Conversion Date (except to the extent made only as of a specified date, in which case as of such date) to Seller as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;4.1</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Organization
and Related Matters</U>. Buyer is a corporation duly organized and validly existing under the laws of the State of Delaware. Buyer has
the corporate power and authority to own or lease all of its properties and assets and to carry on its business as it is now being conducted,
and is duly licensed or qualified to do business in each jurisdiction in which the nature of the business conducted by it or the character
or location of the properties and assets owned or leased by it makes such licensing or qualification necessary, except where the failure
to be so licensed or qualified would not reasonably be expected to have, individually or in the aggregate, a Buyer Material Adverse Effect.
Buyer is duly qualified under the Code (including Section&nbsp;223(d)(1)(B)&nbsp;thereof) and to accept a trustee-to-trustee transfer
of the  Account Assets relating to HSA Accounts from Seller.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;4.2</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Authority;
No Violation</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(a)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Buyer
has all requisite corporate power and authority to execute and deliver this Agreement and to consummate the Transactions. The execution
and delivery of this Agreement and the consummation of the Transactions have been duly and validly approved by all necessary corporate
action on the part of Buyer. No other corporate proceeding on the part of Buyer or its controlled Affiliates is necessary to approve
this Agreement or to consummate the Transactions. This Agreement have been duly and validly executed and delivered by Buyer and, assuming
due authorization, execution and delivery by Seller or an Affiliate thereof, as applicable, this Agreement constitute a valid and binding
obligation of Buyer, enforceable against Buyer in accordance with its terms, except as such enforcement may be limited by (i)&nbsp;the
effect of bankruptcy, insolvency, reorganization, receivership, conservatorship, arrangement, moratorium or other laws affecting or relating
to the rights of creditors generally or (ii)&nbsp;the rules&nbsp;governing the availability of specific performance, injunctive relief
or other equitable remedies and general principles of equity, regardless of whether considered in a proceeding in equity or at law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(b)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Neither
the execution and delivery of this Agreement by Buyer, nor the consummation by Buyer of the Transactions nor compliance by Buyer with
any of the terms or provisions hereof does or will (i)&nbsp;violate any provision of the certificate of incorporation or bylaws of Buyer
or (ii)&nbsp;(A)&nbsp;violate any Applicable Law or (B)&nbsp;violate, conflict with, result in a breach of any provision of or the loss
of any benefit under, constitute a default (or an event which, with notice or lapse of time, or both, would constitute a default) under,
result in the termination of or a right of termination or cancellation under, accelerate the performance required by or rights or obligations
under, or result in the creation of any Lien upon any of the properties or assets of Buyer under any of the terms, conditions or provisions
of any Contract to which Buyer is a party, or by which it or any of its properties, assets or business activities may be bound or affected,
except (in the case of clause&nbsp;(ii)&nbsp;above) for such violations, conflicts, breaches, defaults or loss of benefits which would
not reasonably be expected to have, individually or in the aggregate, a Buyer Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 9; Value: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;4.3</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Consents
and Approvals</U>. Buyer is not required to make any filings, declarations or registrations with any Governmental Authority or obtain
any consents or approvals of any third party or Governmental Authority in connection with (a)&nbsp;the execution and delivery by Buyer
of this Agreement or (b)&nbsp;the consummation by Buyer of the Transactions. There are no pending or threatened disputes or controversies
between Buyer and any Governmental Authority, or investigation or inquiry by any such Governmental Authority, that could reasonably be
expected to have a Buyer Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;4.4</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Legal
Proceedings</U>. There are no Proceedings that are pending or, to the Knowledge of Buyer, threatened against Buyer or any of its controlled
Affiliates or their respective properties, assets or businesses that could reasonably be expected to have, individually or in the aggregate,
a Buyer Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;4.5</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>No
Broker</U>. None of Buyer or any of its Affiliates has employed any broker or finder or incurred any Liability for any broker&rsquo;s
fees, commissions or finder&rsquo;s fees in connection with the Transactions (other than any broker or finder whose broker&rsquo;s fees,
commissions or finder&rsquo;s fees shall be paid solely by Buyer or its Affiliates).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;4.6</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Financing</U>.
Buyer has sufficient cash available to enable Buyer to pay the Purchase Price on the terms and conditions set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;4.7</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Limitations
on Representations and Warranties</U>. Except for the representations and warranties expressly set forth in this Agreement or in any
document delivered pursuant hereto, neither Buyer nor any Affiliate of Buyer nor any of their respective officers, directors, employees,
agents or representatives, nor any other Person, makes or shall be deemed to make any representation or warranty to Seller, express or
implied, at law or in equity, written or oral, with respect to the Transactions, and Buyer hereby disclaims any such representation or
warranty whether by Buyer or any Affiliate of Buyer or any of their respective officers, directors, employees, agents or representatives
or any other Person. Buyer acknowledges that, except as expressly set forth herein, Buyer has not relied upon any representation or warranty,
express or implied, at law or in equity, written or oral, with respect to the Transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;V<BR>
HSA CUSTODIAL TRANSFER MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="color: #010000">Section&nbsp;5.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Notice of Resignation</U>. No more than 45 calendar days and no less than 30 calendar days prior to the Conversion Date,
Seller shall distribute to each HSA Account Holder in accordance with the terms of the applicable Account Agreement (the date of the first
such distribution, the &ldquo;<B>Resignation Notice Date</B>&rdquo;) a duly executed resignation letter, in a form to be mutually agreed
between Seller and Buyer (the &ldquo;<B>Custodian Resignation Letter</B>&rdquo;), pursuant to which <I>inter alia</I> Seller notifies
each HSA Account Holder of its resignation as custodian of the applicable HSA Account effective as of the Conversion Date and designates
Buyer as new custodian of each applicable HSA Continuing Account effective as of the Conversion Date. Notwithstanding Seller&rsquo;s notification
to HSA Account Holders of its resignation pursuant to this Agreement, Seller may continue to enroll new HSA Account Holders pursuant to
existing contractual obligations owed to Enterprise Partner customers of Seller in existence as of the date hereof until the day immediately
preceding the Conversion Date solely to the extent Seller validly resigns as custodian of the applicable newly enrolled HSA Account effective
as of the Conversion Date; <U>provided</U>, that in no event shall Buyer have any obligation to Seller in respect of such HSA Accounts
hereunder. Notwithstanding the foregoing sentence, in no event shall Seller enter into Contracts or arrangements with Enterprise Partners
in respect of any new or existing Accounts following the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;5.2</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Transition
Period Operating Matters</U>. From and after the Signing Date until the Conversion Date (the &ldquo;<B>HSA Transition Period</B>&rdquo;):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;except as
otherwise required by Applicable Law, Seller shall administer the HSA Accounts in the ordinary course of business consistent with
past practice;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;without limiting the generality of the foregoing, except as otherwise required by Applicable Law or this Agreement, (i) Seller shall
credit interest to the HSA Accounts in accordance with Seller&rsquo;s interest rate schedules in effect as of the Signing Date, (ii) Seller
shall not amend in any material respect, terminate or waive the terms of any Account Agreement, and (iii) Seller shall comply with the
obligations set forth on Schedule 2 hereto; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Seller shall use commercially reasonable efforts to assist Buyer in Buyer&rsquo;s efforts to enroll each existing Enterprise Partner
customer of Seller in Buyer&rsquo;s HSA offering effective as of the Conversion Date, including, without limitation, (i) providing reasonable access to Seller&rsquo;s personnel and files associated with each such Enterprise Partner, (ii) facilitating introductory
communications as reasonably requested by Buyer, and (iii) providing information regarding such Enterprise Partner&rsquo;s program design,
file integrations and key processes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;5.3</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Notice
Period Reporting</U>. During the period commencing on the Resignation Notice Date and ending on the Conversion Date (the &ldquo;<B>HSA
Notice Period</B>&rdquo;), Seller shall on a weekly basis provide to Buyer a written schedule identifying (i)&nbsp;each HSA Account that
has been terminated, liquidated or transferred to a third-party trustee or custodian during the Notice Period, (ii)&nbsp;the name of
the applicable HSA Account Holder and related Enterprise Partner, if any, and (iii)&nbsp;the estimated value of the Account Assets held
in such HSA Account on the date of such termination, liquidation or transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;5.4</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Custodial
Resignation</U>. Effective upon the Conversion Date, Seller shall, without any action required on the part of Buyer, resign as custodian
of the HSA Accounts. During the HSA Transition Period, Seller shall use its best efforts to take all steps reasonably requested by Buyer
to designate Buyer as custodian of the Continuing Accounts comprised of HSAs effective as of the Conversion Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;5.5</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Investment
Asset Matters</U>. At a time mutually agreed to by Seller and Buyer, after Seller&rsquo;s consultation with Seller&rsquo;s third
party service provider with respect to Investment Assets, but in any event prior to the Conversion Date, Seller shall cause any and
all Investment Assets held in the Investment Accounts to be liquidated and converted to Cash Assets in accordance with the terms of
the applicable Account Agreements relating to HSA Accounts to facilitate the transfer of such Cash Assets to Buyer in connection
with the Bulk Cash Assets Transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;5.6</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Debit
Card and Online Transaction Processing</U>. At least three (3)&nbsp;Business Days prior to the Conversion Date, Seller shall
terminate all debit card and online transaction processing capabilities in respect of the HSA&nbsp;Accounts.&nbsp; Buyer
covenants and agrees to provide to all HSA Account Holders to whom Seller has delivered a Custodial Resignation Letter on the
Resignation Notice Date in accordance with the terms of this Agreement new debit cards and online transaction processing
capabilities at least three (3)&nbsp;Business Days prior to the Conversion Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 11; Value: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;5.7</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Bulk
Cash Assets Transfer</U>. On the date that is three (3)&nbsp;Business Days prior to the Conversion Date, Seller shall provide Buyer with
a schedule (the &ldquo;<B>Available Balance Report</B>&rdquo;) setting forth (i)&nbsp;the name of each HSA Account Holder, (ii)&nbsp;the
account number associated with such HSA Account Holder&rsquo;s HSA Account and (iii)&nbsp;the total account balance held in such HSA
Account Holder&rsquo;s HSA Account determined as of 11:59 p.m.&nbsp;(Mountain Time) as of such date, and (iv)&nbsp;the employer by whom
such HSA Account Holder is employed. No later than 12:00 p.m.&nbsp;(noon) (Eastern Time) on the Conversion Date, Seller shall provide
Buyer with a final Available Balance Report and, upon direction by Buyer exercising the custodial rights acquired hereunder, Seller shall
send to Buyer by Wire Transfer, to one or more accounts at one or more depository institutions whose deposits are insured by the Federal
Deposit Insurance Corporation, an amount in cash equal to the sum of all Cash Assets included in the final Available Balance Report (the
 &ldquo;<B>Bulk Cash Assets Transfer</B>&rdquo;). From the Conversion Date through the date that is thirty (30) calendar days after the
Conversion Date, Seller and Buyer shall cooperate in good faith to reconcile all Continuing Account balances following the Bulk Cash
Assets Transfer against the Continuing Account balance information set forth in the final Available Balance Report.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;5.8</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Recordkeeping
Matters</U>. From and after the Conversion Date, Seller shall provide Buyer with reasonable access to the Account Files relating to
HSA Accounts upon reasonable advance notice. Such access shall occur only during normal business hours and shall be conducted in a
manner that does not unreasonably interfere with Seller&rsquo;s operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;5.9</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Remittances</U>.
From and after the Conversion Date, Seller shall promptly remit to Buyer by Wire Transfer any amounts received by Seller properly accruing
to the Continuing Accounts that are HSAs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;5.10</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Required
Consents</U>. Each of Buyer and Seller agrees to cooperate with the other, and each will take all commercially reasonable steps necessary,
in order to obtain all Required Consents, including without limitation filing one or more notices or applications with Governmental Authorities
required for the approval by any Governmental Authority of the Transactions. Notwithstanding the foregoing, in no event shall Buyer be
obligated to pay any money (other than immaterial administrative and/or legal costs and expenses) to any Person or offer or grant financial
or other accommodations to any Person in connection with obtaining any such Required Consents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;VI<BR>
NOTIONAL ACCOUNT TRANSITION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;6.1</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Transition
Period Operating Matters</U>. From and after the Signing Date until the applicable Plan Year End (the &ldquo;<B>Notional Account
Transition Period</B>&rdquo;), except as otherwise required by Applicable Law, Seller shall administer the Notional Accounts in the
ordinary course of business consistent with past practice. Without limiting the generality of the foregoing, during the Notional
Account Transition Period, except as otherwise required by Applicable Law or this Agreement, (a)&nbsp;Seller shall not amend,
terminate or waive the terms of any Notional Account Agreement, and (b)&nbsp;Seller shall comply with the obligations set forth on <U>Schedule
2</U> hereto. Seller shall use commercially reasonable efforts to assist Buyer in Buyer&rsquo;s efforts to enroll each existing Enterprise Partner customer
of Seller in Buyer&rsquo;s notional account and other product offerings effective as of the applicable Plan Year End, including, without
limitation, (i) providing reasonable access to Seller&rsquo;s personnel and files associated with each such Enterprise Partner, (ii) facilitating
introductory communications as reasonably requested by Buyer, and (iii) providing information regarding such Enterprise Partner&rsquo;s
program design, file integrations and key processes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 12; Value: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;6.2</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Contractual
Matters; Cooperation</U>. Effective as of the applicable Plan Year End, Seller shall terminate, or cause to be terminated, each Contract with an Enterprise Partner in respect of the
Notional Accounts. In connection with the termination of the Contracts in respect of the Notional Accounts, Seller will ensure that any
grace period and run-out activities for the Notional Accounts are completed by Seller&rsquo;s existing service providers after the termination
of the Notional Accounts. Buyer will offer to each Enterprise Partner whose Contract in respect of Notional Accounts with Seller shall
have been terminated pursuant to this <U>Section&nbsp;6.2</U> a replacement Contract in respect of such Notional Accounts having economic
terms (and only economic terms) substantially similar to or better than those under the terminated Contract with Seller; <U>provided</U>,
that Buyer&rsquo;s obligation under this sentence shall only be effective to the extent Seller shall have provided to Buyer a written
copy of such terminated Contract prior to the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;VII<BR>
OTHER AGREEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;7.1</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Confidentiality
and Announcements; Communications</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(a)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">From
and after the Signing, the Confidentiality Agreement shall terminate and be of no force and effect with respect to any information relating
to this Agreement, the Transactions or the Accounts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(b)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Seller
and its Affiliates shall not, for a period of five (5)&nbsp;years from and after the Signing Date, directly or indirectly, without the
prior written consent of Buyer, disclose or use, any confidential or proprietary information of Buyer or its Affiliates involving or
relating to this Agreement, including the proprietary process by which the Account Assets and related assets are to transfer to Buyer
in connection with this Agreement, or any information related to Enterprise Partners or Account Holders; <U>provided</U>, that the information
subject to the foregoing provisions of this sentence will not include any information generally available to, or known by, the public
(other than as a result of disclosure in violation hereof); <U>provided</U>, <U>further</U>, that the provisions of this <U>Section&nbsp;7.1(b)</U>&nbsp;will
not prohibit (i)&nbsp;any use by Seller of any information related to Enterprise Partners or Account Holders so long as such use does
not violate the provisions of <U>Section&nbsp;7.4(a)</U>&nbsp;of this Agreement or (ii)&nbsp;any retention of copies of records or the
making of any disclosure&nbsp;required by Applicable Law so long as reasonable prior notice is given of such disclosure and a reasonable
opportunity is afforded to the other party, at its cost, to contest the same (to the extent such notice to the other party is legally
permissible and reasonably practicable), or required pursuant to applicable regulatory or supervisory process, examination, inquiry or
request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 13; Value: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(c)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Seller
and Buyer shall cooperate in good faith with respect to the form, substance and timing of any press release or other public disclosure,
if any, related to this Agreement or the Transactions, and neither Seller nor Buyer shall issue any press release or make any public
disclosure without the prior written consent of the other, such consent not to be unreasonably withheld, conditioned or delayed. Notwithstanding
the foregoing, either party may make any public disclosure with respect to this Agreement or the Transactions (i)&nbsp;that is contemplated
by this Agreement, (ii)&nbsp;that is required by Applicable Law or Order or (iii)&nbsp;that references generally, without identifying
the other party or the financial terms of the Transactions, the existence of this Agreement, the intended Conversion Date and the consummation
of the Transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;7.2</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Expenses</U>.
Except as otherwise contemplated hereby, Seller, on the one hand, and Buyer, on the other hand, shall each bear its own costs and expenses
incurred in connection with the negotiation and preparation of this Agreement and the consummation of the Transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;7.3</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Further
Assurances; Wrong Pocket</U>. Each party to this Agreement shall, at the request of the other, at any time and from time to time following
the Signing Date, at the cost of the requesting party, execute and deliver to the requesting party such further instruments as may be
reasonably necessary or appropriate in order to confirm or carry out more effectively the provisions of this Agreement. If at any time
after the Conversion Date (i)&nbsp;Buyer or its designee holds any Excluded Liabilities or (ii)&nbsp;Seller holds any Acquired Assets
or Assumed Liabilities, Buyer or Seller, as the case may be, will promptly transfer (or cause to be transferred) such assets or assume
(or cause to be assumed) such Liabilities to or from (as the case may be) the other party, without further consideration from the other
party. Prior to any such transfer, the party receiving or possessing any such asset will hold it in trust for such other party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;7.4</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Non-Competition</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(a)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Seller
acknowledges and agrees that (i)&nbsp;the agreements and covenants contained in this <U>Section&nbsp;7.4</U> are reasonable and valid
in geographical and temporal scope and in all other respects and are essential to protect the value of the Acquired Assets; (ii)&nbsp;Buyer
has agreed to purchase the Acquired Assets in reliance on the covenants made by Seller in this <U>Section&nbsp;7.4</U>; and (iii)&nbsp;Buyer
would not have agreed to purchase the Acquired Assets in the absence of the covenants made by Seller in this <U>Section&nbsp;7.4</U>.
Therefore, Seller agrees that, during the Restricted Period, neither Seller nor any of its Affiliates shall (1)&nbsp;participate or engage,
directly or indirectly, in the business of acting as trustee or custodian for Health Savings Accounts in the United States or otherwise
offering or administering Health Savings Accounts, Flexible Spending Accounts, Health Reimbursement Arrangements, or Commuter Accounts
in the United States or (2)&nbsp;engage in Interfering Activities. Notwithstanding the foregoing, the parties agree that (I)&nbsp;nothing
in this Agreement shall be construed to prohibit or otherwise limit Seller or any of its Affiliates from generally soliciting financial
services or any other businesses, including but not limited to deposits, loans and other financial products, in any geography or in any
manner, (II)&nbsp;nothing in this Agreement shall be construed to prohibit or otherwise limit Seller or any of its Affiliates from owning,
as a passive investment, an aggregate of less than 5% of any class of voting securities (as defined in 12 C.F.R. &sect; 225.2(q)(1))
outstanding of a corporation or other Person, and (III)&nbsp;nothing in this Agreement shall be construed to prohibit or otherwise limit
Seller or any of its Affiliates from engaging in any commercial or investment banking activities; <U>provided</U>, that such activities
do not involve Seller or its Affiliate engaging in the business of acting as trustee or custodian for Health Savings Accounts in the
United States or otherwise offering or administering Health Savings Accounts, Flexible Spending Accounts, Health Reimbursement Arrangements,
or Commuter Accounts in the United States. The parties further agree that this <U>Section&nbsp;7.4(a)</U>&nbsp;shall not apply to any
Person acquired by Seller or any of its Affiliates after the Conversion Date (an &ldquo;<B>Acquired Person</B>&rdquo;) to the extent
that the business, operations, assets, liabilities, sales, revenues, profits, expenses or losses of such Acquired Person, in the twelve
(12) calendar month period prior to its acquisition by Seller or its Affiliate, were not primarily dedicated to, derived from or attributable
to the business of acting as trustee or custodian for Health Savings Accounts in the United States or otherwise offering or administering
Health Savings Accounts, Flexible Spending Accounts, Health Reimbursement Arrangements, or Commuter Accounts in the United States, and
Seller or its Affiliates shall be permitted to continue the business as operated by an Acquired Person in the ordinary course of business
and consistent with the past practice of such Acquired Person prior to such acquisition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 14; Value: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(b)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">If
any court of competent jurisdiction shall at any time deem the duration or the geographic scope of any of the provisions of this <U>Section&nbsp;7.4
</U>unenforceable, the other provisions of this <U>Section&nbsp;7.4</U> shall nevertheless stand and the duration and/or geographic scope
set forth herein shall be deemed to be the longest period and/or greatest size permissible by Applicable Law, and the parties agree that
such court shall reduce the time period and/or geographic scope to permissible duration or size.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(c)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Without
limiting the remedies available to Buyer, Seller acknowledges that a breach of any of the covenants contained in this <U>Section&nbsp;7.4
</U>may result in material irreparable injury to Buyer for which there is no adequate remedy at law, that it will not be possible to
measure damages for such injuries precisely and that, in the event of such a breach or threat thereof, Buyer shall be entitled to obtain
a temporary restraining order and/or a preliminary or permanent injunction (without the necessity of proving irreparable harm or injury
as a result of such breach or threatened breach hereof, restraining Seller from engaging in activities prohibited by this <U>Section&nbsp;7.4</U>),
or such other relief as may be required specifically to enforce any of the covenants in this <U>Section&nbsp;7.4</U>. Notwithstanding
any other provision to the contrary, the Restricted Period shall be tolled during any period of violation of any of the covenants in
this <U>Section&nbsp;7.4</U> and during any other period required for litigation during which Buyer seeks to enforce such covenants against
Seller if it is ultimately determined that Seller was in breach of such covenants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;7.5</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Employee
Matters</U>. Prior to the Conversion Date, Buyer may, or may cause one of its Affiliates to, extend offers of employment to certain employees
of Seller or its Affiliates whose primary job responsibilities involve the Accounts (each, an &ldquo;<B>Offeree Employee</B>&rdquo;).
All such offers of employment to Offeree Employees shall be on terms acceptable to Buyer. Nothing in this Agreement shall be construed
as an employment contract between Buyer and any Offeree Employee. Further, nothing contained in this Agreement will prohibit Seller from
attempting to retain the employment, by any lawful means, of one (1)&nbsp;Offeree Employee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 15; Value: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Split-Segment; Name: 3 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;VIII<BR>
TAX MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;8.1</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Tax
Cooperation</U>. Each Party shall cooperate and provide to the other Party hereto such information and assistance as may reasonably be
requested in connection with (i)&nbsp;the preparation of any Tax Return relating to the Accounts, the Continuing Accounts or the Acquired
Assets, (ii)&nbsp;the conduct of any audit or other examination by any Taxing Authority relating to any liability for Taxes relating
to the Accounts, the Continuing Accounts or the Acquired Assets, and (iii)&nbsp;the prosecution or defense of any claim, suit or proceeding
relating to any Tax Return relating to the Accounts, the Continuing Accounts or the Acquired Assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;8.2</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Transfer
Taxes</U>. All transfer, documentary, sales, use, stamp, registration, value added and other such Taxes and fees (including any penalties
and interest) imposed on Buyer or Seller or any of their Affiliates in connection with this Agreement and the sale of the Acquired Assets
(&ldquo;<B>Transfer Taxes</B>&rdquo;) will be borne and entirely by Buyer when due, and Buyer, at its own expense, will cause to be filed
all necessary Tax Returns and other documentation with respect to all such Transfer Taxes and Seller shall cooperate and, as required
by Applicable Law, join in the execution of all necessary Tax Returns and other documentation with respect to Transfer Taxes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;8.3</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Tax
Reporting</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(a)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Form&nbsp;1099-SA</U>.
Seller and Buyer shall issue Form&nbsp;1099-SA to all HSA Account Holders and the Internal Revenue Service reporting all reportable distributions
made as provided below. Seller agrees to provide Buyer with necessary HSA transaction history to support 2021 tax reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="padding: 5 5.4pt; width: 52%; border: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="padding: 5 5.4pt; width: 24%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2020
    1099-SA</B></FONT></TD>
    <TD STYLE="padding: 5 5.4pt; width: 24%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2021
    1099-SA</B></FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 5 5.4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>HSA
    Account Population</B></FONT></TD>
    <TD STYLE="padding: 5 5.4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Distributions
    made in <BR>
2020</B></FONT></TD>
    <TD STYLE="padding: 5 5.4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Distributions
    made in <BR>
2021</B></FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 5 5.4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-converted
    HSA Accounts (e.g., HSA Accounts closed and not converted to Buyer)</FONT></TD>
    <TD STYLE="padding: 5 5.4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller</FONT></TD>
    <TD STYLE="padding: 5 5.4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 5 5.4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    converted HSA Accounts (e.g., Continuing Accounts)</FONT></TD>
    <TD STYLE="padding: 5 5.4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller</FONT></TD>
    <TD STYLE="padding: 5 5.4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buyer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(b)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Form&nbsp;5498-SA</U>.
Seller and Buyer shall issue Form&nbsp;5498-SA to all HSA Account Holders and the Internal Revenue Service reporting all reportable contributions
made as provided below. Seller agrees to provide Buyer with necessary HSA transaction history to support 2021 tax reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="padding: 5 5.4pt; border: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding-top: 5; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; padding-bottom: 5"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2020
    5498-SA</B></FONT></TD>
    <TD COLSPAN="3" STYLE="padding-top: 5; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; padding-bottom: 5"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2021
    5498-SA</B></FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 5 5.4pt; width: 14%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>HSA
    Account<BR>
Population</B></FONT></TD>
    <TD STYLE="padding: 5 5.4pt; width: 14%; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2020<BR>

    contributions </B></FONT><B><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif">&ndash; Box 2</FONT></B></TD>
    <TD STYLE="padding-top: 5; width: 14%; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center; padding-bottom: 5"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Contributions<BR>
made in 2020<BR>
 designated<BR>
for 2019 tax<BR>
year (Prior<BR>
Year) </B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif">&ndash;
    Box <BR>
2</FONT></B></TD>
    <TD STYLE="padding: 5 5.4pt; width: 15%; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Contributions<BR>
made in 2021<BR>
 designated<BR>
for 2020 tax<BR>
year<BR>
    (Prior Year) </B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
 &ndash; Box 3</FONT></B></TD>
    <TD STYLE="padding-top: 5; width: 14%; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center; padding-bottom: 5"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2021<BR>
Contributions </B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
 &ndash; Box 2</FONT></B></TD>
    <TD STYLE="padding-top: 5; width: 14%; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center; padding-bottom: 5"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Contributions<BR>

    made in 2021<BR>
 designated<BR>
for 2020 tax<BR>
 year (Prior<BR>
 Year)</B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif">&ndash;
    Box 2</FONT></B></TD>
    <TD STYLE="padding: 5 5.4pt; width: 15%; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Contributions<BR>

    made in 2022<BR>
 designated<BR>
for 2021 tax <BR>
year (Prior<BR>
Year)</B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif">&ndash;
    Box 3</FONT></B></TD></TR>
  <TR>
    <TD STYLE="padding: 5 5.4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-converted
    HSA Accounts (e.g., HSA Accounts closed and not converted to Buyer)</FONT></TD>
    <TD STYLE="padding: 5 5.4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller</FONT></TD>
    <TD STYLE="padding-top: 5; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; padding-bottom: 5"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller</FONT></TD>
    <TD STYLE="padding: 5 5.4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller</FONT></TD>
    <TD STYLE="padding-top: 5; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; padding-bottom: 5"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller</FONT></TD>
    <TD STYLE="padding-top: 5; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; padding-bottom: 5"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller</FONT></TD>
    <TD STYLE="padding: 5 5.4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 5 5.4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    converted HSA Accounts (e.g., Continuing Accounts)</FONT></TD>
    <TD STYLE="padding: 5 5.4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller</FONT></TD>
    <TD STYLE="padding-top: 5; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; padding-bottom: 5"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller</FONT></TD>
    <TD STYLE="padding: 5 5.4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller</FONT></TD>
    <TD STYLE="padding-top: 5; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; padding-bottom: 5"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buyer</FONT></TD>
    <TD STYLE="padding-top: 5; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; padding-bottom: 5"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buyer</FONT></TD>
    <TD STYLE="padding: 5 5.4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buyer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(c)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Buyer
and Seller shall retain, in accordance with their respective standard recordkeeping policies and procedures, and provide the other party
with all records or other information that may be reasonably relevant to the preparation of Forms 1099-SA and 5498-SA contemplated by
this <U>Section&nbsp;8.3</U>. Buyer agrees to indemnify Seller for any penalty, interest, claim, fee (including reasonable attorney&rsquo;s
fees) or other liability or expense which may be imposed upon or asserted against Seller as a result of Buyer&rsquo;s failure to timely
and accurately report such reportable payments, as required by Applicable Law, unless such failure by Buyer is due to Seller&rsquo;s
failure to provide to Buyer in a timely manner the amount of such reportable payments earned or paid by the customers through the Conversion
Date. Seller agrees to indemnify Buyer for any penalty, interest, claim, fee (including reasonable attorney&rsquo;s fees) or other liability
or expense which may be imposed upon Buyer as a result of Buyer&rsquo;s failure to timely and accurately report reportable payments earned
or paid by Account Holders if Buyer&rsquo;s failure is caused by Seller&rsquo;s failure to provide in a timely manner the amount of Account
Holder contributions and distributions through the Conversion Date or errors in such information provided by Seller to Buyer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(d)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">For
purposes of Section&nbsp;223 of the Code, the parties shall treat this transaction as a trustee to trustee transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;IX<BR>
CONDITIONS TO CONVERSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;9.1</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Conditions
to Obligations of Buyer</U>. Unless waived in writing by Buyer, the obligation of Buyer to consummate the Transactions is conditioned
upon satisfaction of each of the following conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(a)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Orders</U>.
No Governmental Authority of competent jurisdiction shall have enacted, issued, promulgated, enforced or entered any Order (whether temporary,
preliminary or permanent) that is in effect and that prohibits, makes illegal or materially and adversely affects the consummation of
the Transactions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Value: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(b)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Representations
and Warranties</U>. The representations and warranties of Seller contained in this Agreement shall be true and correct in all material
respects as of the date of this Agreement and as of the Conversion Date as though such representations and warranties were made at and
as of such time (except that representations and warranties as of a specified date need only be true on and as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(c)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Covenants
and Other Agreements</U>. Seller shall have performed, in all material respects, its covenants, promises and agreements in this Agreement
on or prior to the Conversion Date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(d)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Master
Services Agreement</U>. Buyer and Seller shall have entered into the Master Services Agreement to be effective as of the Conversion Date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(e)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Seller
Officers&rsquo; Certificate</U>. Buyer shall have received a certificate dated as of the Conversion Date and executed by a duly authorized
officer of Seller to the effect that each of the conditions specified above in this <U>Section&nbsp;9.1</U> are satisfied in all material
respects; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(f)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Required
Consents</U>. All Required Consent shall have been obtained and shall be in full force and effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;9.2</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Conditions
to Obligations of Seller</U>. Unless waived in writing by Seller, the obligation of Seller to consummate the Transactions is conditioned
upon satisfaction of each of the following conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(a)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Orders</U>.
No Governmental Authority of competent jurisdiction shall have enacted, issued, promulgated, enforced or entered any Order (whether temporary,
preliminary or permanent) that is in effect and that prohibits, makes illegal or materially and adversely affects the consummation of
the Transactions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(b)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Representations
and Warranties</U>. The representations and warranties of Buyer contained in this Agreement shall be true and correct in all material
respects as of the date of this Agreement and as of the Conversion Date as though such representations and warranties were made at and
as of such time (except that representations and warranties as of a specified date need only be true on and as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(c)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Covenants
and Other Agreements</U>. Buyer shall have performed, in all material respects, its covenants and agreements herein on or prior to the
Conversion Date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(d)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Master
Services Agreement</U>. Buyer and Seller shall have entered into the Master Services Agreement to be effective as of the Conversion Date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(e)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Buyer
Officers&rsquo; Certificate</U>. Seller shall have received a certificate dated as of the Conversion Date and executed by a duly authorized
officer of Buyer to the effect that each of the conditions specified above in this <U>Section&nbsp;9.2</U> are satisfied in all material
respects; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(f)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Required
Consents</U>. All Required Consent shall have been obtained and shall be in full force and effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;X<BR>
TERMINATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;10.1</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Termination
of Agreement</U>. This Agreement may be terminated at any time prior to the Conversion Date:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(a)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">by
the mutual written agreement of Buyer and Seller;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(b)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">by
Buyer if (i)&nbsp;at the time of such termination any of the representations and warranties of Seller contained in this Agreement shall
not be true and correct to the extent that the condition set forth in <U>Section&nbsp;9.1(b)</U>&nbsp;cannot be satisfied, or (ii)&nbsp;there
shall have been any material breach of any covenant, agreement or obligation of Seller hereunder to the extent that the condition set
forth in <U>Section&nbsp;9.1(c)</U>&nbsp;cannot be satisfied, and, in the case of (i)&nbsp;or (ii), such breach or failure is not or
cannot be remedied by Seller within thirty (30) calendar days after receipt of notice in writing from Buyer specifying the nature of
such breach or failure and requesting that it be remedied; <I>provided</I> that Buyer may not terminate this Agreement based upon the
failure of the conditions set forth in <U>Section&nbsp;9.1(b)</U>&nbsp;or <U>9.1(c)</U>&nbsp;to be satisfied if such failure was primarily
caused by Buyer&rsquo;s breach of this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(c)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">by
Seller, if (i)&nbsp;at the time of such termination any of the representations and warranties of Buyer contained in this Agreement shall
not be true and correct to the extent that the condition set forth in <U>Section&nbsp;9.2(b)</U>&nbsp;cannot be satisfied, or (ii)&nbsp;there
shall have been any breach of any covenant, agreement or obligation of Buyer hereunder to the extent that the condition set forth in
<U>Section&nbsp;9.2(c)&nbsp;</U>cannot be satisfied, and, in the case of (i)&nbsp;or (ii), such breach or failure is not or cannot be
remedied by Buyer within thirty (30) calendar days after receipt of notice in writing from Seller specifying the nature of such breach
or failure and requesting that it be remedied; <I>provided</I> that Seller may not terminate this Agreement based upon the failure of
the conditions set forth in <U>Section&nbsp;9.2(b)</U>&nbsp;or <U>9.2(c)</U>&nbsp;to be satisfied if such failure was primarily caused
by Seller&rsquo;s breach of this Agreement; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(d)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">by
Seller or Buyer, in the event the Conversion Date has not occurred by December&nbsp;31, 2021 (or such other date mutually agreed between
the parties in writing), unless the failure to so consummate is primarily due to a breach of this Agreement by the party seeking to terminate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;10.2</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Effect
of Termination</U>. In the event of termination of this Agreement, except for any provision that expressly survives termination of this
Agreement, no party hereto, or any of its directors, officers, employees, agents or Affiliates, shall have any liability or further obligation
to any other party, except that neither Seller nor Buyer shall be relieved or released from any liabilities or damages arising out of
any willful breach of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;XI<BR>
INDEMNIFICATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;11.1</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Survival
of Representations and Warranties and Agreements</U>. The respective representations and warranties of Seller and Buyer contained in
this Agreement shall survive the Signing but shall expire on, and no claim for indemnification for any breach of representation or warranty
hereunder may be made after the date that is 15 calendar months after the Conversion Date, except with respect to, and to the extent
of, any claim of which written notice in accordance with <U>Section&nbsp;11.4</U> has been given in good faith by one party to the other
prior to such date; <U>provided</U>, that, notwithstanding the foregoing, (i)&nbsp;the representations and warranties set forth in <U>Section&nbsp;3.9
</U>(Taxes) shall terminate upon the expiration of the applicable statute of limitations and (ii)&nbsp;(A)&nbsp;the Seller Fundamental
Representations, (B)&nbsp;the Buyer Fundamental Representations and (C)&nbsp;any action relating to fraud or intentional misrepresentation
shall survive indefinitely. The respective covenants and agreements of Seller and Buyer contained in this Agreement shall survive the
Signing in accordance with their terms. The period from the Signing to the expiration, if any, of a representation, warranty, covenant
or agreement hereunder shall be referred to with respect to a claim for indemnification thereunder as the &ldquo;<B>Survival Period</B>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;11.2</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Indemnification
by Seller</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(a)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Subject
to the provisions of this <U>ARTICLE&nbsp;XI</U>, Seller shall indemnify, defend and hold harmless Buyer and its Affiliates and its and
their respective stockholders, officers, directors, employees, representatives and agents (collectively, the &ldquo;<B>Buyer Indemnitees</B>&rdquo;)
from and after the Signing Date from and against any and all claims, losses, damages, Liabilities, awards, judgments, costs and expenses
(including reasonable attorneys&rsquo; fees) (&ldquo;<B>Damages</B>&rdquo;) incurred by the Buyer Indemnitees to the extent caused by:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(i)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">any
breach of any of the representations and warranties made in this Agreement by Seller or in any certificate or instrument delivered by
or on behalf of Seller pursuant to this Agreement; <U>provided</U>, that in the case of any such representation or warranty that is limited
by &ldquo;materiality,&rdquo; &ldquo;Material Adverse Effect&rdquo; or any similar term or limitation, the amount of Damages shall be
determined as if such &ldquo;materiality,&rdquo; &ldquo;Material Adverse Effect&rdquo; or similar term or limitation were not included
therein;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(ii)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">any
breach of any covenant or agreement of Seller made herein, including, but not limited to, failing to liquidate and convert Investment
Assets held in the Investment Accounts to Cash Assets as required by <U>Section&nbsp;5.5</U>; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(iii)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">any
Excluded Liability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(b)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Notwithstanding
the foregoing, (i)&nbsp;Seller shall not be liable to indemnify any Buyer Indemnitees against Damages arising under <U>Section&nbsp;11.2(a)(i</U>)&nbsp;for
any claim (or series of related claims) where the amount of Damages with respect to such claim (or related claims) does not exceed $10,000
(the &ldquo;<B>De Minimis Amount</B>&rdquo;) (and the amount of such Damages shall not be aggregated for purposes of clause (ii)&nbsp;of
this sentence); (ii)&nbsp;Seller shall not be liable to indemnify any Buyer Indemnitees against Damages arising under <U>Section&nbsp;11.2(a)(i</U>)&nbsp;
unless and until the aggregate amount of such Damages exceeds three hundred twenty five thousand U.S. dollars ($325,000) (the &ldquo;<B>Threshold
Amount</B>&rdquo;), whereupon the Buyer Indemnitees shall be entitled to indemnification for the amount of such Damages in excess of
the Threshold Amount; and (iii)&nbsp;Seller&rsquo;s maximum Liability to the Buyer Indemnitees for all Damages arising under <U>Section&nbsp;11.2(a)(i</U>)&nbsp;shall
not exceed six million five hundred thousand U.S. dollars ($6,500,000) (the &ldquo;<B>Maximum Amount</B>&rdquo;); <U>provided</U>, that
the Threshold Amount and Maximum Amount shall not apply with respect to any failure of the Seller Fundamental Representations to be true
and correct, in which case Seller&rsquo;s maximum Liability to the Buyer Indemnitees shall not exceed the Purchase Price. Notwithstanding
anything herein to the contrary, the limitations set forth in this <U>Section&nbsp;11.2(b)</U>&nbsp;shall not apply in respect of any
indemnification obligation to the extent arising out of or resulting from fraud or willful misrepresentation by Seller.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;11.3</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Indemnification
by Buyer</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(a)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Subject
to the provisions of this <U>ARTICLE&nbsp;XI</U>, Buyer shall indemnify, defend and hold harmless Seller and its Affiliates and their
respective stockholders, officers, directors, employees, representatives and agents (collectively, the &ldquo;<B>Seller Indemnitees</B>&rdquo;)
from and after the Signing Date from and against any and all Damages incurred by the Seller Indemnitees to the extent caused by:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(i)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">any
breach of any of the representations and warranties made in this Agreement by Buyer or in any certificate or instrument delivered by
or on behalf of Buyer pursuant to this Agreement; <U>provided</U>, that in the case of any such representation or warranty that is limited
by &ldquo;materiality,&rdquo; &ldquo;Material Adverse Effect&rdquo; or any similar term or limitation, the amount of Damages shall be
determined as if such &ldquo;materiality,&rdquo; &ldquo;Material Adverse Effect&rdquo; or similar term or limitation were not included
therein;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(ii)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">any
breach of any covenant or agreement of Buyer made herein; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(iii)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">any
Assumed Liability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(b)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Notwithstanding
the foregoing, (i)&nbsp;Buyer shall not be liable to indemnify any Seller Indemnitees against Damages arising under <U>Section&nbsp;11.3(a)(i)</U>&nbsp;for
any claim (or series of related claims) where the amount of Damages with respect to such claim (or related claims) does not exceed the
De Minimis Amount (and the amount of such Damages shall not be aggregated for purposes of clause (ii)&nbsp;of this sentence); (ii)&nbsp;Buyer
shall not be liable to indemnify any Seller Indemnitees against Damages arising under <U>Section&nbsp;11.3(a)(i)</U>&nbsp;unless and
until the aggregate amount of such Damages exceeds the Threshold Amount, whereupon the Seller Indemnitees shall be entitled to indemnification
for the full amount of such Damages (inclusive of the Threshold Amount); and (iii)&nbsp;Buyer&rsquo;s maximum Liability to the Seller
Indemnitees for all Damages arising under <U>Section&nbsp;11.3(a)(i)</U>&nbsp;shall not exceed the Maximum Amount; <U>provided</U>, that
the Threshold Amount and Maximum Amount shall not apply with respect to any failure of the Buyer Fundamental Representations to be true
and correct, in which case Buyer&rsquo;s maximum Liability to the Seller Indemnitees shall not exceed the Purchase Price. Notwithstanding
anything herein to the contrary, the limitations set forth in this <U>Section&nbsp;11.3(b)</U>&nbsp;shall not apply in respect of any
indemnification obligation to the extent arising out of or resulting from fraud or willful misrepresentation by Buyer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;11.4</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Indemnification
Procedure</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(a)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Promptly
after the incurrence of any Damages by the party seeking indemnification hereunder (the &ldquo;<B>Indemnified Party</B>&rdquo;), the
Indemnified Party shall deliver to the party from which indemnification is sought (the &ldquo;<B>Indemnifying Party</B>&rdquo;) a notice
(the &ldquo;<B>Claim Notice</B>&rdquo;), which Claim Notice shall be delivered within the relevant Survival Period; <U>provided</U>,
that the failure to provide such notice shall not release the Indemnifying Party from any of its obligations under this <U>ARTICLE&nbsp;XI
</U>except to the extent that the Indemnifying Party is materially prejudiced by such failure, and shall:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(i)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">state
that the Indemnified Party has paid or properly accrued Damages for which such Indemnified Party is entitled to indemnification pursuant
to this Agreement; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(ii)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">specify
in reasonable detail each individual item of Damages included in the amount so stated to the extent known, to whom such item was paid
or is anticipated to be paid to the extent known, the date such item was paid or properly accrued and the nature of the breach of representation,
warranty, covenant or agreement and the computation of the amount, if reasonably capable of computation, to which such Indemnified Party
claims to be entitled hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(b)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Claims
for Damages specified in any Claim Notice with respect to which the parties agree in writing to be due, or which are determined by final,
non-appealable order of a court of competent jurisdiction to be due, are hereinafter referred to, collectively, as &ldquo;<B>Agreed Claims</B>.&rdquo;
Within ten (10)&nbsp;Business Days of the determination of the amount of any Agreed Claim, subject to the limitations of this <U>ARTICLE&nbsp;XI</U>,
the Indemnifying Party shall pay to the Indemnified Party an amount equal to the Agreed Claim by Wire Transfer to the bank account or
accounts designated in writing by the Indemnified Party not less than one (1)&nbsp;Business Day prior to such payment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(c)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Promptly
after the assertion by any third party of any claim against any Indemnified Party that may result in the incurrence by such Indemnified
Party of Damages for which such Indemnified Party would be entitled to indemnification pursuant to this Agreement, such Indemnified Party
shall deliver to the Indemnifying Party a Claim Notice; <U>provided</U>, that the failure to provide such notice shall not release the
Indemnifying Party from any of its obligations under this <U>ARTICLE&nbsp;XI</U> except to the extent that the Indemnifying Party is
materially prejudiced by such failure, and the Indemnifying Party shall have thirty (30) days after receipt of the Claim Notice to elect,
at its option, to assume and control the defense of, at its own expense and by its own counsel (who shall be reasonably acceptable to
the Indemnified Party), such claim, and the Indemnifying Party shall be entitled to assert any and all defenses available to the Indemnified
Party to the fullest extent permitted by Applicable Law. If the Indemnifying Party shall, in accordance with the previous sentence, undertake
to compromise or defend any such claim, it shall reasonably promptly notify the Indemnified Party of its intention to do so, and the
Indemnified Party agrees in such case to cooperate fully with the Indemnifying Party and its counsel in the compromise of, or defense
against, any such claim. Notwithstanding an election by the Indemnifying Party to assume the defense of such action or proceeding, the
Indemnified Party shall have the right to employ separate counsel and to participate in, but not control, the defense of such action
or proceeding. The Indemnifying Party shall bear the reasonable fees, costs and expenses of one (1)&nbsp;firm of such separate counsel
(such single firm representing all Indemnified Parties), if, but only if, (i)&nbsp;the Indemnified Party shall have been advised by counsel
that an actual or potential conflict of interest makes representation by the same counsel or the counsel selected by the Indemnifying
Party inappropriate or (ii)&nbsp;the Indemnifying Party shall have authorized in writing the Indemnified Party to employ separate counsel
at the Indemnifying Party&rsquo;s expense. In any event, the Indemnified Party and Indemnifying Party and their counsel shall cooperate
in the defense of any such claim subject to this <U>Section&nbsp;11.4(c)</U>, including keeping such Persons informed of all material
developments relating to any such claims, and providing copies of all relevant material correspondence and documentation relating thereto
and also including, as required, the furnishing of personnel and witnesses and the execution of documents in each case as necessary for
any defense of such third-party claim and at no cost to the other party (subject to reasonable out-of-pocket expenses of the Indemnified
Party incurred in connection with such defense being considered part of Damages hereunder). If the Indemnifying Party receiving such
Claim Notice does not elect within thirty (30) days to defend such third-party claim, the Indemnified Party shall have the right, at
the Indemnifying Party&rsquo;s expense, to defend such claim; <U>provided</U>, that the Indemnifying Party shall not be liable for the
fees and expenses of more than one (1)&nbsp;firm of counsel for all Indemnified Parties. No Indemnifying Party shall be liable to indemnify
any Indemnified Party for any settlement of any such action or claim effected without the consent of the Indemnifying Party, but if settled
with the written consent of the Indemnifying Party, or if there be a final judgment for the plaintiff in any such action, the Indemnifying
Party shall indemnify and hold harmless each Indemnified Party from and against any Damages by reason of such settlement or judgment,
subject to the limitations set forth in this <U>Article&nbsp;XI</U>. If the Indemnifying Party shall assume the defense of any claim
in accordance with the provisions of this <U>Section&nbsp;11.4(c)</U>, the Indemnifying Party shall obtain the prior written consent
of the Indemnified Party (which shall not be unreasonably withheld, conditioned or delayed) before entering into any settlement of such
claim, but only if the settlement does not release the Indemnified Party from all Liabilities and obligations with respect to such claim,
or the settlement is in excess of the remaining portion of the Maximum Amount set forth in <U>Section&nbsp;11.2</U> or <U>Section&nbsp;11.3</U>,
as applicable, or if the settlement imposes injunctive or other non-monetary equitable relief against the Indemnified Party. The Indemnified
Party and the Indemnifying Party each agrees to cooperate fully in all matters covered by this <U>Section&nbsp;11.4(c)</U>, including,
as required, the furnishing of books and records, personnel and witnesses and the execution of documents, in each case as necessary for
any defense of such third-party claim and at no cost to the other party (provided that any reasonable out-of-pocket expenses of the Indemnified
Party incurred in connection with the foregoing shall be considered part of Damages hereunder).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(d)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Anything
to the contrary in this <U>Section&nbsp;11.4</U> notwithstanding, if a third-party claim that primarily relates to Taxes or Excluded
Taxes includes or could reasonably be expected to include both a claim for Taxes that are Excluded Taxes and a claim for Taxes that are
not Excluded Taxes, and such claim for Taxes that are Excluded Taxes is not separable from such a claim for Taxes that are not Excluded
Taxes, Seller (if the claim for Taxes that are Excluded Taxes exceeds or reasonably could be expected to exceed in amount the claim for
Taxes that are not Excluded Taxes) or otherwise Buyer (Seller or Buyer, as the case may be, the &ldquo;<B>Controlling Party</B>&rdquo;),
shall be entitled to control the defense of such third-party claim (such third-party claim, a &ldquo;<B>Tax Claim</B>&rdquo;). In such
case, the other party (Seller or Buyer, as the case may be, the &ldquo;<B>Non-Controlling Party</B>&rdquo;) shall be entitled to participate
fully (at the Non-Controlling Party&rsquo;s sole expense) in the conduct of such Tax Claim and the Controlling Party shall not settle
such Tax Claim without the consent of such Non-Controlling Party (which consent shall not be unreasonably withheld, conditioned or delayed).
The costs and expenses of conducting the defense of such Tax Claim shall be reasonably apportioned based on the relative amounts of the
Tax Claim that are Excluded Taxes and the Tax Claim that are not Excluded Taxes. Notwithstanding the foregoing, Seller shall be entitled
to control in all respects, and neither Buyer nor any of its Affiliates shall be entitled to participate in, the defense of any third-party
claim that relates to any income Taxes of Seller or any of its Affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;11.5</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Certain
Damages; Certain Offsets; Calculation of Damages</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(a)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">In
no event shall an Indemnifying Party have liability to the Indemnified Party for any punitive or exemplary damages except if and to the
extent any such damages are recovered against an Indemnified Party pursuant to any component of any claim, settlement, award or judgment
against such Indemnified Party by any unaffiliated third party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(b)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">For
purposes of calculating the monetary amount of Damages for which any claim may be made against any Indemnifying Party, such monetary
amount shall be decreased to the extent of any amounts actually recovered by an Indemnified Party under insurance policies, net of any
increase in premiums directly attributable to such recovery for the year of the claim and the following year, deductibles or co-pays
incurred in connection therewith, including reasonable costs of collection.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(c)</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Each
Indemnified Party will use its commercially reasonable efforts to mitigate each loss or Liability for which such Indemnified Party is
or may become entitled to be indemnified hereunder, including by (i)&nbsp;using commercially reasonable efforts in pursuing and attempting
to recover any insurance proceeds available to it as a result thereof and (ii)&nbsp;incurring costs only to the extent reasonably appropriate
to remedy any breach or remediate any other situation. If such Indemnified Party mitigates its loss after the Indemnifying Party has
paid the Indemnified Party under this <U>Article&nbsp;XI </U>in respect of that loss, the Indemnified Party must notify the Indemnifying
Party and pay to the Indemnifying Party the extent of the value of the benefit to the Indemnified Party of that mitigation (less the
Indemnified Party&rsquo;s reasonable costs of mitigation) promptly after the benefit is received.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;11.6</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Exclusive
Remedy</U>. The parties acknowledge and agree that their sole and exclusive remedy with respect to any and all claims (other than claims
arising from fraud, criminal activity or willful misconduct on the part of a party in connection with the Transactions) for any breach
of any representation or warranty set forth herein shall be pursuant to the indemnification provisions set forth in this <U>ARTICLE&nbsp;XI</U>.
Nothing in this <U>Section&nbsp;11.6</U> shall limit any party&rsquo;s right to seek and obtain any equitable relief to which such party
shall be entitled hereunder or to seek any remedy on account of any party&rsquo;s fraudulent, criminal or willful misconduct.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;11.7</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Treatment
of Indemnification Payments</U>. Any amounts payable under this <U>ARTICLE&nbsp;XI</U> shall for all purposes be treated by Buyer and
Seller as an adjustment to the Purchase Price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;XII<BR>
MISCELLANEOUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;12.1</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Amendments;
Waiver</U>. This Agreement may not be amended, altered or modified except by written instrument executed by each of the parties. No waiver
of any party to this Agreement will be effective unless it is in a writing signed by a duly authorized officer of the waiving party that
makes express reference to the provision or provisions subject to such waiver. No waiver shall constitute a waiver of, or estoppel with
respect to, any subsequent or other inaccuracy, breach or failure to strictly comply with the provisions of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;12.2</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Entire
Agreement</U>. This Agreement (including the Seller Disclosure Schedule, the Confidentiality Agreement and any other schedules, certificates,
lists and documents referred to herein or therein, and any documents executed by any of the parties simultaneously herewith or pursuant
thereto), constitutes the entire agreement of the parties, and supersedes all prior agreements and understandings, discussions, negotiations
and communications, written and oral, among the parties with respect to the subject matter hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;12.3</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Interpretation</U>.
When a reference is made in this Agreement to Articles, Sections, Schedules or Exhibits, such reference shall be to an Article&nbsp;of,
Section&nbsp;of, Schedule to or Exhibit&nbsp;to this Agreement unless otherwise indicated. The table of contents and headings contained
in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement. Whenever
the words &ldquo;include,&rdquo; &ldquo;includes&rdquo; or &ldquo;including&rdquo; are used in this Agreement, they shall be deemed to
be followed by the words &ldquo;without limitation.&rdquo; The phrases &ldquo;the date of this Agreement,&rdquo; &ldquo;the date hereof&rdquo;
and terms of similar import, unless the context otherwise requires, shall be deemed to refer to the date set forth in the first paragraph
of this Agreement. The word &ldquo;extent&rdquo; in the phrase &ldquo;to the extent&rdquo; shall mean the degree to which a subject or
other thing extends, and such phrase shall not mean simply &ldquo;if&rdquo; unless the context in which such phrase is used shall dictate
otherwise. References to &ldquo;<B>dollars</B>&rdquo; or &ldquo;<B>$</B>&rdquo; mean United States dollars, unless otherwise clearly
indicated to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;12.4</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Severability</U>.
Any term or provision of this Agreement that is invalid or unenforceable in any jurisdiction shall, as to that jurisdiction, be ineffective
to the extent of such invalidity or unenforceability without rendering invalid or unenforceable the remaining terms and provisions of
this Agreement or affecting the validity or enforceability of any of the terms or provisions of this Agreement in any other jurisdiction.
If any provision of this Agreement is so broad as to be unenforceable, the provision shall be interpreted to be only so broad as is enforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;12.5</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Notices</U>.
Unless otherwise provided herein, all notices and other communications hereunder shall be in writing and shall be deemed given if (i)&nbsp;delivered
in person, (ii)&nbsp;transmitted by email (<U>provided</U>, that a copy of the notice or other communication is sent by overnight courier)
or (iii)&nbsp;delivered by an overnight courier, to the parties at the following addresses (or at such other address for a party as shall
be specified by like notice):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">If to Seller, to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Fifth Third Bank, National Association<BR>
38 Fountain Square Plaza</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cincinnati,
Ohio 45263</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.75in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Michael L. Powell, Deputy General
Counsel, Senior Vice President</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.75in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">michael.powell2@53.com</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">With a copy to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dinsmore&nbsp;&amp;
Shohl LLP<BR>
255 East Fifth Street, Suite&nbsp;1900<BR>
Cincinnati, Ohio 45202</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.75in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Michael G. Dailey and Christian
Gonzalez</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.75in; text-align: left"><FONT STYLE="font-size: 10pt">Email:</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">michael.dailey@dinsmore.com</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.75in; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">christian.gonzalez@dinsmore.com</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">If to Buyer, to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HealthEquity,&nbsp;Inc.<BR>
15 W. Scenic Pointe Drive, Suite&nbsp;100<BR>
Draper, UT 84020</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.75in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Jon Kessler, Chief Executive Officer</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 2.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">Delano</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">W. Ladd, General Counsel</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.75in; text-align: left"><FONT STYLE="font-size: 10pt">Email:</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">JKessler@healthequity.com</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.75in; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">legal_dept@healthequity.com</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;12.6</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Binding
Effect; Persons Benefiting; No Assignment</U>. This Agreement shall inure to the benefit of and be binding upon the parties and their
respective successors and assigns and any Buyer of all or substantially all of the assets of such party and its subsidiaries taken as
a whole. This Agreement may not be assigned by any of the parties without the prior written consent of Buyer, in the case of any assignment
by Seller, and Seller, in the case of any assignment by Buyer. Except as otherwise expressly set forth in <U>ARTICLE&nbsp;XI</U>, no
provision of this Agreement is intended or shall be construed to confer upon any entity or Person other than the parties and their respective
successors and permitted assigns any right, remedy or claim under or by reason of this Agreement or any part hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;12.7</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Counterparts</U>.
This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which taken together
shall constitute one and the same agreement, it being understood that all of the parties need not sign the same counterpart. A copy of
this Agreement or signature page&nbsp;hereto signed and transmitted by facsimile machine, as an attachment to an email or by other electronic
means (collectively an &ldquo;<B>Electronic Document</B>&rdquo;), shall be treated as an original document. The signature of any party
thereon, for purposes hereof, is to be considered an original signature, and the Electronic Document transmitted is to be considered
to have the same binding effect as an original signature on an original document. At the request of any party, any Electronic Document
shall be re-executed in original form by the party or parties who executed the Electronic Document. No party may raise the use of an
Electronic Document or the fact that a signature was transmitted through the use of a facsimile machine, email or other electronic means
as a defense to the enforcement of this Agreement or any amendment or other document executed in compliance with this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;12.8</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Waiver
of Jury Trial</U>. The parties hereby waive, to the fullest extent permitted by law, any right to trial by jury of any claim, demand,
action or cause of action arising under this Agreement or in any way connected with or related or incidental to the dealings of the parties
in respect of this Agreement or any of the Transactions, in each case, whether now existing or hereafter arising, and whether in contract,
tort, equity or otherwise. The parties hereby further agree and consent that any such claim, demand, action or cause of action shall
be decided by court trial without a jury and that the parties may file a copy of this Agreement with any court as written evidence of
the consent of the parties to the waiver of their right to trial by jury.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;12.9</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Governing
Law; Venue</U>. This Agreement and any claim, demand, action or cause of action arising under this Agreement shall be governed by, and
construed in accordance with, the laws of the State of Delaware applicable to contracts made and wholly performed within such state,
without regard to any applicable conflicts of law principles. The parties irrevocably submit to the exclusive jurisdiction of the courts
of the State of Delaware and to the jurisdiction of the United States District Court for the District of Delaware over any suit, action
or proceeding arising out of or relating to this Agreement or any of the Transactions. To the fullest extent that they may effectively
do so under Applicable Law, the parties irrevocably waive and agree not to assert, by way of motion, as a defense or otherwise, any claim
that they are not subject to the jurisdiction of any such court, any objection that they may now or hereafter have to the laying of the
venue of any such suit, action or proceeding brought in any such court and any claim that any such suit, action or proceeding brought
in any such court has been brought in an inconvenient forum.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;12.10</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Specific
Performance</U>. The parties hereby acknowledge and agree that the failure of any party to perform its agreements and covenants hereunder,
including its failure to take all actions as are necessary on its part to consummate the Transactions, will cause irreparable injury
to the other party, for which damages, even if available, will not be an adequate remedy. Accordingly, each party hereby consents to
the issuance of temporary, preliminary and permanent injunctive relief by the courts referenced in <U>Section&nbsp;12.9</U> to compel
performance of such party&rsquo;s obligations, or to prevent breaches or threatened breaches of this Agreement, and to the granting by
the courts referenced in <U>Section&nbsp;12.9</U> of the remedy of specific performance of its obligations hereunder, without, in any
such case, the requirement to post any bond or other undertaking, in addition to any other rights or remedies available hereunder or
at law or in equity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;12.11</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>No
Third-Party Beneficiary</U>. This Agreement will not confer any rights or remedies upon any Person other than the parties hereto and
their respective heirs, executors, successors and permitted assigns.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;12.12</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Bulk
Sales Waiver</U>. The parties waive compliance with any &ldquo;bulk sales&rdquo; and similar laws applicable to the Transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature Pages&nbsp;to Follow]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">IN WITNESS WHEREOF, the parties have caused this
Custodial Transfer and Asset Purchase Agreement to be executed as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SELLER:</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FIFTH THIRD BANK, NATIONAL ASSOCIATION</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 46%">/s/ Bryan Preston</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Bryan Preston</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Senior Vice President</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">/s/ Brennen Willingham</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Name: Brennen Willingham</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title: Senior Vice President</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BUYER:</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HEALTHEQUITY,&nbsp;INC.</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Tyson Murdock</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Tyson Murdock</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Chief Financial Officer</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Signature Page&nbsp;to Custodial Transfer and
Asset Purchase Agreement]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 14; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>tm2114113d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm2114113d1_ex99-1img001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Fifth Third Bank HSAs Moving to HealthEquity</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-size: 10pt"><B>Draper, Utah
 &ndash; (</B></FONT>GLOBE NEWSWIRE<B>) &ndash; April&nbsp;27, 2021</B> &ndash; HealthEquity,&nbsp;Inc. (NASDAQ: HQY) (&ldquo;HealthEquity&rdquo;
or the &ldquo;Company&rdquo;), the largest independent HSA custodian, today announced&nbsp;it has entered into a definitive agreement
with Fifth Third Bank, National Association (&quot;Fifth Third&quot;), to transition custodianship of Fifth Third&rsquo;s health savings
account (HSA) portfolio to HealthEquity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">The definitive agreement contemplates a
$60.8 million dollar purchase price for a transfer of approximately 149,000 current HSA members and their approximately $477.0
million of HSA assets. The definitive agreement includes a mechanism to adjust the purchase price based on the amount of HSA assets
actually transferred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&quot;We are eager to welcome Fifth Third
HSA members and employers to HealthEquity with remarkable Purple service from HSA experts and the industry&rsquo;s leading platform for
connecting health and wealth,&quot; said HealthEquity's CEO, Jon Kessler</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&ldquo;HealthEquity has a culture and dedication
to taking care of its customers,&rdquo; said Tim Spence, president of Fifth Third Bancorp. &ldquo;We believe this transition is the best
path forward for our HSA members to maintain the highest quality of delivery in services now and in the future.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The transition of custodianship of Fifth Third Bank&rsquo;s HSA portfolio
to HealthEquity, which will also entail a transfer of the underlying assets held in the HSAs, is subject to regulatory approval and satisfaction
of other customary closing conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About&nbsp;HealthEquity</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">HealthEquity and its subsidiaries administer
HSAs and other consumer-directed benefits for our more than 12 million accounts in partnership with employers, benefits advisors, and
health and retirement plan providers who share our mission to connect health and wealth and value our culture of remarkable &ldquo;Purple&rdquo;
service. For more information, visit </FONT><U>www.healthequity.com</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward-looking statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">This press release contains &ldquo;forward-looking
statements&quot; within the meaning of the &ldquo;</FONT>safe harbor&rdquo; provisions of the Private Securities Litigation Reform Act
of 1995, including but not limited to, statements regarding our industry, business strategy, plans, goals and expectations concerning
our markets and market position, product expansion, future operations, expenses and other results of operations, revenue, margins, profitability,
future efficiencies, tax rates, capital expenditures, liquidity and capital resources and other financial and operating information. When
used in this discussion, the words &ldquo;may,&rdquo; &ldquo;believes,&rdquo; &ldquo;intends,&rdquo; &ldquo;seeks,&rdquo; &ldquo;anticipates,&rdquo;
 &ldquo;plans,&rdquo; &ldquo;estimates,&rdquo; &ldquo;expects,&rdquo; &ldquo;should,&rdquo; &ldquo;assumes,&rdquo; &ldquo;continues,&rdquo;
 &ldquo;could,&rdquo; &ldquo;will,&rdquo; &ldquo;future&rdquo; and the negative of these or similar terms and phrases are intended to identify
forward-looking statements in this press release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Forward-looking statements reflect our current expectations regarding
future events, results or outcomes. These expectations may or may not be realized. Although we believe the expectations reflected in the
forward-looking statements are reasonable, we can give you no assurance these expectations will prove to be correct. Some of these expectations
may be based upon assumptions, data or judgments that prove to be incorrect. Actual events, results and outcomes may differ materially
from our expectations due to a variety of known and unknown risks, uncertainties and other factors. Although it is not possible to identify
all of these risks and factors, they include, among others, risks related to the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD><TD>the impact of the transition of Fifth Third&rsquo;s HSA portfolio on the Company and our results of operations;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD><TD>Fifth Third&rsquo;s ability to receive the necessary regulatory approval;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD><TD>the impact of the COVID-19 pandemic on the Company, its operations and its financial results;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD><TD>our ability to realize the anticipated financial and other benefits from combining the operations of WageWorks with our business in
an efficient and effective manner;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD><TD>our ability to compete effectively in a rapidly evolving healthcare and benefits administration industry;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD><TD>our dependence on the continued availability and benefits of tax-advantaged health savings accounts and other consumer-directed benefits;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD><TD>our ability to successfully identify, acquire and integrate additional portfolio purchases or acquisition targets;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD><TD>the significant competition we face and may face in the future, including from those with greater resources than us;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD><TD>our reliance on the availability and performance of our technology and communications systems;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD><TD>recent and potential future cybersecurity breaches of our technology and communications systems and other data interruptions, including
resulting costs and liabilities, reputational damage and loss of business;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD><TD>the current uncertain healthcare environment, including changes in healthcare programs and expenditures and related regulations;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD><TD>our ability to comply with current and future privacy, healthcare, tax, investment advisor and other laws applicable to our business;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD><TD>our reliance on partners and third-party vendors for distribution and important services;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD><TD>our ability to develop and implement updated features for our technology and communications systems and successfully manage our growth;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD><TD>our ability to protect our brand and other intellectual property rights; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD><TD>our reliance on our management team and key team members.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For a detailed discussion of these and other risk factors, please refer
to the risks detailed in our filings with the Securities and Exchange Commission, including, without limitation, our most recent Annual
Report on Form&nbsp;10-K and subsequent periodic and current reports. Past performance is not necessarily indicative of future results.
We undertake no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future
events or otherwise. Forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date
of this press release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor Relations Contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Richard Putnam</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">801-727-1209</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>rputnam@healthequity.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection Last; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>hqy-20210427.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.7a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaCKSbOdzZR+aYkxtmBxbblKTy8pSwYKYC2dr4+WsWgP -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:hqy="http://healthequity.com/20210427" elementFormDefault="qualified" targetNamespace="http://healthequity.com/20210427">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://healthequity.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="hqy-20210427_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="hqy-20210427_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>hqy-20210427_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.7a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>hqy-20210427_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.7a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://healthequity.com/role/Cover" xlink:href="hqy-20210427.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://healthequity.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>tm2114113d1_ex99-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2114113d1_ex99-1img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  L /<# 2(  A$! Q$!_\0
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M*^TCK_B-_P D_P!7_P"N2_\ H:U'\,_^2>:3_NR?^C'J3XB@GP!J^!G]TO\
MZ&M9OPOUG39?!VFZ:E[ ;Z,2;K?>/,'SL<[>N,$&N=)NA\_T,_L?,Y;PE:Q7
M'QLUIY%#&![F5,CHV\+G\F->JZVBR:#J*,,JUK*"/^ FO,/!?_):/$7TN?\
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MGDFKU%%W:P7.9UOP!X<UZY:YN['9<L<M+ Q0M]<<'ZD9IVA^ _#OA^X%S96
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7  ?05T%7B*JJ2TV0ZDN9Z!1116!!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>tm2114113d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="hqy-20210427.xsd" xlink:type="simple"/>
    <context id="From2021-04-27to2021-04-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
        </entity>
        <period>
            <startDate>2021-04-27</startDate>
            <endDate>2021-04-27</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2021-04-27to2021-04-27">0001428336</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2021-04-27to2021-04-27">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2021-04-27to2021-04-27">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2021-04-27to2021-04-27">2021-04-27</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2021-04-27to2021-04-27">HealthEquity, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2021-04-27to2021-04-27">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2021-04-27to2021-04-27">001-36568</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2021-04-27to2021-04-27">52-2383166</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2021-04-27to2021-04-27">15 West Scenic Pointe Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2021-04-27to2021-04-27">Suite&#160;100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2021-04-27to2021-04-27">Draper</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2021-04-27to2021-04-27">UT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2021-04-27to2021-04-27">84020</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2021-04-27to2021-04-27">801</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2021-04-27to2021-04-27">727-1000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2021-04-27to2021-04-27">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2021-04-27to2021-04-27">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2021-04-27to2021-04-27">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2021-04-27to2021-04-27">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2021-04-27to2021-04-27">Common stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2021-04-27to2021-04-27">HQY</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2021-04-27to2021-04-27">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2021-04-27to2021-04-27">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140137840191816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Apr. 27, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr. 27,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36568<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">HealthEquity, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001428336<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">52-2383166<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">15 West Scenic Pointe Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite&#160;100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Draper<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">UT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">84020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">801<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">727-1000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HQY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MKW#.RW^0\Y^M<\TUMTQ>DO:C_S=7^2V,D_'T7!S1JP,Z6PE<A!OZ%>Y7>>9
M]IV03NA1.XJRY/K%.?7A'=O["_PJOE]?\HIUTNUF<$//\A=>BD[E\ZI[J,NX
MZBQ_AOMHD<VWL,\E=,E[7FY'U=;[021>\%G'!QR>(W?#$T<PGX#%$<"P/!@#
MS"=X87G^I_VLT/T$#..VBB(KU&>%^@2O&+(=/EB>N$_NG_A.\SQ-LPRKZ'8;
M9;#%ZI9E\!>/AG$##RP/9'I;K?%NXQ/R^AQ@/7UM0K"=XI.([12O-2#QNH%'
MGL>[C>4!#ZP+V.Q _G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G
M)$WS/(X %F>0IA@"IQ%', ;  4/2='@//GL?)=-[*CG_5U/\!%!+ P04
M" !,AIM2EXJ[',     3 @  "P   %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">
M, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]
M$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA<
MUYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A
M(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X
M4$L#!!0    ( $R&FU*JQ"(6,P$  "("   /    >&PO=V]R:V)O;VLN>&UL
MC5'1;L(P#/R5*A^P%K0A#5%>0-N0I@V-B??0NM0BB2O'A8VOG]NJ&M)>]I3<
MV;K<7187XM.!Z)1\>1=B;FJ19IZFL:C!VWA'#02=5,3>BD(^IK%AL&6L <2[
M=)IEL]1;#&:Y&+6VG-X"$B@$*2C9$7N$2_R==S Y8\0#.I3OW/1W!R;Q&-#C
M%<K<9":)-5U>B/%*0:S;%4S.Y68R#/; @L4?>M>9_+2'V#-B#Q]6C>1FEJE@
MA1REW^CUK7H\@RX/J!5Z0B? :ROPS-0V&(Z=C*9(;V+T/8SG4.*<_U,C5146
ML*:B]1!DZ)'!=09#K+&))@G60VY6= ;N\N@#FW+()FKJIBF>HPYX4P[V1D\E
M5!B@?%.9J+SV4VPYZ8Y>9WK_,'G4'EKG5LJ]AU>RY1AQ_)[E#U!+ P04
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MUDX:?^:+X3]>?P%02P$"% ,4    " !,AIM2!T%-8H$   "Q    $
M        @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( $R&FU*9
MZAM%[P   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM
M;%!+ 0(4 Q0    ( $R&FU*97)PC$ 8  )PG   3              "  <T!
M  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ 3(:;4A[99KM0!
MVA   !@              ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;%!+ 0(4 Q0    ( $R&FU*?H!OPL0(  .(,   -              "  90,
M  !X;"]S='EL97,N>&UL4$L! A0#%     @ 3(:;4I>*NQS     $P(   L
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64$L%!@     )  D /@(  .@3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2114113d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="tm2114113d1_8k.htm">tm2114113d1_8k.htm</File>
    <File>hqy-20210427.xsd</File>
    <File>hqy-20210427_lab.xml</File>
    <File>hqy-20210427_pre.xml</File>
    <File>tm2114113d1_ex2-1.htm</File>
    <File>tm2114113d1_ex99-1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "tm2114113d1_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2114113d1_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "hqy-20210427_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "hqy-20210427_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "hqy-20210427.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "hqy",
   "nsuri": "http://healthequity.com/20210427",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2114113d1_8k.htm",
      "contextRef": "From2021-04-27to2021-04-27",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://healthequity.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2114113d1_8k.htm",
      "contextRef": "From2021-04-27to2021-04-27",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r9",
      "r11",
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r10": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r11": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r12": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r13": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r14": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r15": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r16": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "Section",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001104659-21-055660-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-21-055660-xbrl.zip
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M:LVY:)<]E?GF>:8D.EKSETE,$IGWR;':&*N-\?&T;+&_D[M^GW$Y&KA8I9G
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MF%ZOL0H\+.KIYV9\\9K'KX32GQE_90N"4\Y(7-R!L3UWZM:[?2^GQW;SU1Q
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M%*]59DBH7BLWSC)5,OBD]U"%I4M2A?I,T73(;C)TYNT,MCY&S[$CZ6[W;9#
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M+2M=3%[5GN^#1XH%3SAFZ;%'.5.TG)2]N3*5[S,)<?>UP.(G'+P,FR6=06?
M1<X?X3TS;!5G* N^%M@L$ YDALT2KP+0/7M9FJCPN/V>$,N<</INI35"U,.4
M"7&99UQ"%NQM]H18U(3S="NM$:*^2D%/;&?W0:NYF:Y6M(:0>QI@T1/.Q@U:
MI4S!XN=Z^G*E7Y!_A1K]K@9"^%Z3M"\DB6,WL:.\VLN$:0_[D!Y+GW0AJ=\H
M"?\;,P6]?:=5A#2P-5]H^D5]*VPN2$I=K&G**^_6>PV"%]X='98Z85%;98QR
M15@^$CSN"\6"]_$[,BQEP@JVPA8AY$LF'W0^,_'R5JL8P W59)OO'Z*,0NX
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M %(0W$P!@K^+MU[_03@[A?6RAC-!G/1.\7';$#'&+3Z&;CTG/( 1E5*A5$Y
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M 1Q M#O4SSJ> TO <6C-; Q]!%M)A0RT)XN;*NS;DT"P=3IW(#C7UNN(NSP
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MRIPD7=]69_58,_Z2!=?YZJWG\Q1<04>)"#44AGL"#UDX'-6:X;H TI3&;[P
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MX0#D)^+6Y \G_3Y6/<$?PKA;QL;WEPMGMY0[BXCQ@*6<>KDA=23.HQL%7L1
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M\3S"QXK!O<,83IJ]#?YK<VL3_E=-VEAPK_O ZG?^_E]OWO$7VOYMNDM3_/$
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M.(^^!U_0_\%(.U@^]H+H.WQ\<0T&6G!QG98Y8]#A6^:23RFV-_B$#%L'J+C
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MDB.V["Q-S5;&AVFU/I;(;JV7"Y\@'/;JBI&6+!:F#TRD@W]9>2@F'C@HWSX
MN4KG4:R!0_//=VH(<S=/55-K,)XU&,5MPJG_EBR'"?C76C!) R>=XRR4W)9
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MI&TN(ZP#$JF(\/L0I@>5?<_?9WJ+84&>[#''CF1)EPGO]V1[SL7E2U81;??
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MK%70ME3N^CA6&J%XN?DM"&+FO[Q1(UW3;A+(2UK@.P7"O9D:)B[:1@)MC1J
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MWO]Z]($O,NVGZ3V-OJKNS\O0E(91F$L_M\&AO,].A#> 2ZK+R,$2Q\OL^P6
MM\3KC VK(RPYM-5@?L&8W:#^RRSE\3R'=5$>ZWSPU"3RA*F2Z0GD[<<3R ^0
MP_SZ]Q/#YFU@?S>\3G==K_'7#U,4PX&Y-\::K!BV[.V/(H5U\*Y%#+O#I"+6
M'Q;#\L![RN' BF$V2R>7P]N-<GC[X7)8BG*IS66E*K=5$,."+F7Q'.='K"S&
MHR=%?;I=Z0W+BGK ^CJ4TXJEX%+7?P!';G )>X(>OK/580K%M50ZW$I'4_PZ
MNU88X<9]@HT;BEN0=;S!=5FM/;#KAB3 /1#8H,'##$7N5A76@+!U9^K:?F*<
M@*.DOND.SOI@+DR\:4:1F4= HDT:F3FD " %99P@#8=ECMS-BLOL6 RU5>\$
M BXP3 PHIW/#)J*^HUV1PP;*R^PFND$:A_K]5E><&R:I["%N_MYQ&B]CAKD7
MH3619C#1DL.!GY!E)!TIXD&Y4M(1W#9H[KB14K]/.FJB,J.C9!4^ ?/HF99$
MQ;PIO5>B(OI(CGJBS[J-NB*X2=TP( H95$@+D:9T!T#&%9[B 8P;E&T&<P?'
M)BT+4E!X*;9H[I=QZ\&;_V,U6<[HY;/+&;U:YHR>-$]PQ(F"H^.#PR_'1Y^.
M]I?)@K$J:>LIDP7GI!\P(0X2[JS!'?W30:G!KU7,$@/^#'W6Q"%&VX'+]6V%
MJZJ* Q0E1@KR'#8;@;%+_2DHNP@]BZ0CS,E,0D2Z43,7(8 !-9_6EU:J^R-&
MK2#C!8O2^IV2)6' '[EF!F>H4;-;N]:%&\ [7>?.E17+TV@U8@B3^0M0ZQ+B
MUG5R<6$Z[##36\&0F0Q)1_2M8U@E-ZOZ4K"S7A(T NU>\LJO8%83_.I5FO;0
M)(5O@4&9)MJ@E*&00D;HL&2##/+P'3[$.HE?/W1H/M"<*' ,1*>FO5*4G%<I
M_-:Q_O0$49"Q_N'.QALX[O#@M8OP.Q))"8V-<4N-!TK;Q+%_8"$MA1>,LR@9
M-(K@:'<D-K2QMN<,6O;Q)]@?(2.[5U<JYP=>\Z/S#=[NSA<:S]O:O@XCP9)+
M30 8,F$A=GT_"TNR;I!S*\&/X4:#*/<G40=@],G!<]"/D@CIKFJ'MA4]>-=Q
M;4;M.J<5G#(YKJW<>[A2.0]I".(R%6O-/>KF/.@%I'@;S$^'4;/^JW?, >Z8
M-Z/0APTSV7/MV(U]12X@/*QR*!$%U2I0"GNOD!V[O\<]#": &M2R-3BE%T.-
MM_'WC#^==^-QM@KP"7VR(W]!G:@0*;CE0LUQCON\O/R+'&I#D2E><&[\-5CA
MJC5*6LH#/1I^PTX 8E(EC.2Y3F/X)\P&%+.QN7)TAZV3:_Y$10 -?*)I]]LU
M,P6ZKK/C3SM>M"O);DQ%/LGB->POR#>-1YV*I.'!R58N%%9C?/P@HF9]=47\
MWYYCD&C92G$P^[E0:I+NP=]A<DCVP=CB-,]QC.(T=X+/UID& P6$;@_^^U?9
MNQ+"S&Z:BTH1%L=\=64\)Z3!J#(GY)I]P0-^J/M:L&HV:F?UJS,)E6R!R;[-
M/W"%_]W8C9(G/M[1(Q_OB8XQ[#80NUYR:++\F.Z!4P^)VEAPQ+DG%\=,?\V+
MK*2K>RJ&,Y4)5RYFH!(P"$ N]!W[9UAF>6G(>/W40*,%7$T@X1@:ZHI<?\-X
M$F2!2H)"CH#&,D1@U<@!T!]]T3"'/2Z\"SC*J*\2AR>'>\8AFUOX-VOE=BHL
MHW+4C&FTNM)3;$XS^%OG5AYC9.VCX@(K#,ZSQ% L7+&:9?Z-I]D=W\<[OP\]
MN=KD#CR+VYXD.K.\D)W :(,.^?.XW++YR1G&'(DX ''T[S+JZ2H#:74!PAZT
M9,'<-'N@GJCB*>[IPV<_MNTPX%[[87X=R.455N>J>[F[L8MG>B'R?S/<=8^Q
M[2;?<(??62(8"V0T_V;Z9,'XW6<7C/]M&8Q?2#]PKI"QQWZPD1/P3=%&S^L3
MY _F!&/ET]RC(JN[$]H[.JBD#3G\TQ!MW09W>2U"!2+/[Z<99Q<YH$2@ IAQ
MCHQ3E ^D&CM<Z\$M:LD6XZP:HB*+S-ZT>JM>JACI@&%G^/M_;VUV8(' '_/]
MR ,5?(D2T,!@X-(S/8=KC>D@:AT(?(M1IC6\ N5/+!44-W,YR6%4X(DY@54&
M!448ZL6@9E>MOW,^G?6BK:X(; -?']X[BGD2] NV30?/-='P*S!YX($47[Q5
M:.OW.4*:ECG>]>O&^08L4@RV,'CZ_[VSO8O+ S/N+\\%W"G'8 )8.[7EZ?"&
M,?'N^E288"?&C8N8@YU-&9(Q:XS<(/!>>6Y)//2@9,N\TU%S?_T,QFH0?H\&
MY< J;^VFUP=,V1H8\L/7S@%'RM;/H^\!R,"8WA47P2Q,RV*\ZNQN;C8NQQ=Y
MD_I:M#B%S1-&\^7?R]GLF*08U4/2L-<KR.9Z0J*67V"8'$)$F89 ,**$E.*D
M$KFK#U\P.VR9;;SLM,RZUWC?TRSJJHV@)JWA91 ->:79"N3VU-X".6OH-S<M
MXV6$&HN :2^XN,'JA$:)F4YV7%97JB?!0:+Z@20?+L)($^P\8D"9)D>C022U
M_(R-4<R_Z3K;5,#.;%,!MHW <IU^SDR "R";)!'@9$0;,@&4 ##L D^7 9!1
M32<%8)6_'W&O/W09<G^V(7<^1S\><>?[+ /NRX#[(AS>.0ZXZX))$V]?1K'G
M*8J]E^<@#A<UB+U@QNIBABM=T_2.P%>#*7;OR-<.14\<IWE>PI6$)*S%)J<9
MCPS:PY%"JS:[5;'12(Q,/B <60]!56.'#>.>)'A(! @,]47FHY:!, 8H1]](
M;,[J<-9K,42_7KXU(J5[%?Q0$+$VX8U1+3]@-XN W]UXX@GC??>:W+F-]^W,
M>[QO0=KG3I:I?O7L,M6OEYGJ133]&BI@9A9//LW2KNJ!"%\&E.<]H Q+-1@6
M2-IC Z82_L13+[ZWMBD:B_"K^L56BE3RB&:?@ (]Q5OX:5VR?FO7B.Z56)K6
M6#P"4DJLX*N#0*L62>Z+MD'\_^U=:4\<5[K^CL1_*%EW)"R5"<9V-F>L87-,
MAF!?@Z\578VN#MW5ID)U54\M,)U??]_U+-6G&^( !M-?$@/=56=]U^=]7N(0
MF1E%8J3.; 8RL$-6_"']L9^.Q@'X?W=&I L!6B84JMW.SC&2T2N<F36NT*X2
MZA>/1T$^PM9FZ;\1[0"I!A=@8'^RKD9<"MXKKT&,<,_$LPA<?J95ZG%^FLC[
M\L9OG &VPN_=,!]P;-WG+DD=J^@RB'ZW@NA8-)AY1W'VCF*AY<3D0V;?KR99
MC6PA@P%8Y$,K/-!!X;M"^S[[%#@JBQ ;&BJ7Y%<8*[\/Y-8/)GHK+$WH>OCE
M+\.LA;O.O.<P]1R$&%)V@HLU]H,H&I?73(>XUTU%U:M9KVXX.2NK"\PU5'"X
M0+31V:)'7LBAI-1+CH$$D)3Y1!]QDO&1C3]-JYYG'Q<]XQJA<814^-.\ZFN0
MZ[.UFV%<6Q^(C9,Z3>F,O/6@VE"[N$CV-*%%EF9+G<W!5 LOW>H*!Z.T'X+>
M/ZO$E^;;70ZQDM71<#S*A@-M P')4 :F23_@PH?#9W*B0^@3L/'1&'89D>7P
M%[#K@)>^.T&D7VF*%#%HY1,SF62FX/-(';JH?GE0=76[H!N8]QY\/$=-E"#.
MEBWCC?'Q 7 MG96VQ0Q5O"Q^(?+JRD<QP+(R67NZ8>-M#8R_:6#QIJZM4C9#
M(N1'&W%)_?<@1QZA,E24^"&=2U 9'#B+F$ULSTV,C4K-JDM3ZJ# 1P<Y*A_T
MAX;[\A%)(Z@#V<C9SR>F/*-"=9H31K^U;F28-?DG)L@.6P+&!T&E+,SU94HB
M5%A[&EG;)*14@'E]3=Q"WSVX(-$/RR#1O51>=XI8-A9[,$V#>!J.)!,]_VE>
M#\7?5R0 B38?P#4KE\A9038;#F&K+>F%-M3_]+Z[NO).WW-EI^6BZHKA96#S
M^2B?=*Y=%HU[1#2%"?3[/-30YX807$3F.F((Q,KS&2&$U94_$4-8J%&)H\^G
MHXVST!*7D6\VP6@S-#I 8Q.#+$QZ8@UL0Q 'K=ALZZH0.V*$=  )$1O)ERY*
M90F@C\,$]->H?YNLP&:FE<_78BU\4-&P;I* #0T'>VR4L'? ALFER]$[MWS[
M DRD3 +6Z!P66=._O9?KQ9&_8%8T:UK=6VR]BAQ.--TM1T9T8"[6D_W1PA&F
M<QAU\!2<YU7GDM<I'[W6G&44(4 C$\YIWA LS\)<I\$"Y9J1]-9Y(F*)[L5H
MGN$C1]^R$^'<A\AQ:E<]%LPDVYJJ2W@4=,MPK.A/$CZU*S0K.N^^"R!7SXOB
M ;WICE([Y093HBPIT][L9S*6:%'2(1?Q.V< [L"'AYP?K>V=R4G&7"E!/1;&
M=N5.PF'/,6"+5XV PK"U(/=Q572NPAI&G@J[\@F65VM-M5R^=,' *!C@1L:$
M3 NNAZDE9&NC&"/"+\^2?E#*U+=_1WD]MF_O3V5U98U_#Z_$A^)G;9" ]@)>
MWU\P\,X>H]_/,Z:&J?A#0#*V<)&9HGQXG@L]OQT,B5]T* ;41077J**##3_
MJH[@RI)<S*G!8M-*=^39Y"\.H0%KT6Z9 "7TQX8.F(-6^TNO4@0\KPE&6.I<
M,+4!Z_HELMUUX0M<V.C*S#]I).7C+[,  MEXHK3%FT64MNE<9VTX[S(SEXY=
M()J*%0@40^L=Y_ :A]YG'#/P7%C$/2:"Y"S+)OA_>M*[K&ZH;WO)C5CI-87?
M1W (TRNJ"1.F^41MX6@:%G]L7W []XD J5C,2NK#-BTAK$8SJ=  EOYAPVI
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M7F[/DT(V-N=L>V<H?@+54"+ZTH)7+#TWN0]<B9GZ=".8BW7<12CPBV0M3A&
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MO)U0</C'Y "YA>Y9V/&V W=S M2ZU-]LO]W]C0IQWQS_>@#_^']02P,$%
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M:BFE_6TL^(ZUCQ GK]LCRB8P7>XV7!_Z^SN&ICW6UUN3Y+U3UJ2Z36+UDMR
M]V."]^OWOYP<M7N[4#O(;RJC-7ANN:.@)2!7IT/+M"< ]P:J'TVM%#Y7H-G1
M:G^1565\\7JFZMC<\JB.&",XY4BZ,POJ6],ZK.4*'GNE]+7Q!W0T9W54()'<
M@ER7.;;UAP1@I9%+PB#F#'BU,9 G8B!0<RZL6&HH<=<GG&F>RQ@?Q$PEL^5]
MFKLG(I76CF+]<;"WC^KT:*/B1U5Q68Z!C#:@>'G"$C,^XS(I;6!%EQ0)^$V;
MQS. !9P\7BN!6![4?\F9_\8$GHJ7FR(B6CXNJ&*AS,:17T>?"AG\F<Z\)G0.
M"H?V]V\(#LM,K:R0<&<[KE_(\RQ5 &UT_<A,SF!VB8C+7;T.0;K7SES0V8H(
M!_ +_V'E*KQ^3> "OYTJ(WQ@GX ^6'_@'LZZW<5=L='VXWJV%HGD-6B_!>A@
M:^[&P;49.X)F133-5*(FX1I#I6F1A4(0P\S"6)%N]/IX>J5#E,"6<V4)H8&_
MX7@]6E )C+_X6S#*T:.I,'](L[6 [4Z>">ZU+LK3Z H#F@V?P_E*#!,B/<S-
M69>[,-,B+VQ9?!GSE-)WUT@9MZ8R%=@8TZ.&A/+JICJ\KS-XD<VD5AE=/-0#
M %5'3H2[SZHUSK4",TB7][WEW6@HN/ '\N&\;W-4^^CA82V]2T+596D0[L+%
M TM.1041F.!2V^Y"G&QB)HQU932AUJ:&( F?&SK43;#;<,53/P/8J/_)L(.R
MF"K<ADL=M^G1@LW@Q$K[LJR8LG<Y*AQC=+E 2L2?N&191KE1Z5/QZ%C,1*+R
M4D^)+W4K\MB?ZX&P.V0NR^V^G!RLY(B0'85U&F&BU=Q.-P;P5 P T=B6Y1DC
M39I; C.QNH0*(ZA8  VIAG[AO]MG7$7,1HM/!9E]>1QYF7-@*WCJ%'DM%OY#
M*'SO?#UWIF_<EWYB0;7DP*)E5=NRY*-6Q"?-];+N(_<UEEJ,J:HXU';X@H]J
M/.F%-H8GT%&DXS34K%812<,?WW@62]=6H<BW1G%;KI\J0BUD*,?UA<G&LI"%
M#;(,'M1L7 @*A*0N["WU NMUVS\&P!P9=Q=L*=^6*I:1Q]C L[3K;#KLG!N[
MDI*'$IGRKERZ,W?_K0Q?IQ;H6;A.ZS0;5Z$4W_)K0?5*KD+-UUD YT=)60<*
MR?E00,^U '$CF2_8_=51]&4 X33BOBGBIZ0U9-#Z2LVR7U2SX8N0W,34;XXY
M7)GS?>57O@YP6>B5R&5!% D)4])>0O7I3 HBERZ3I)6[S=1$'6R#'KM2UZ^L
M[F[_\.#$46N([T*$? FFFEFXPMX#%TU?2+B"CMEY83.>/N# /W1[[9<[+]N]
MG>[N0PKGPX'.W5K_<U<Q_)/6ZQ?4B^STV7M_X+)'XUX*]V48=@IXZ+-?Z&L&
M://WU91\V3[_=+%)>Z7*HY1"GPT7.?8YT* T49^=\51X29TIVOK.2FE(V8O>
ML/8C5I%LT]];\'^ @?Y.P_\!4$L! A0#%     @ 3(:;4@;R'HA$ P  F0P
M !               ( !     &AQ>2TR,#(Q,#0R-RYX<V102P$"% ,4
M" !,AIM2@2J @?X*  #@AP  %               @ %R P  :'%Y+3(P,C$P
M-#(W7VQA8BYX;6Q02P$"% ,4    " !,AIM2,ZXS]%P'   \60  %
M        @ &B#@  :'%Y+3(P,C$P-#(W7W!R92YX;6Q02P$"% ,4    " !,
MAIM2>Y4#U-H>   'FP  $@              @ $P%@  =&TR,3$T,3$S9#%?
M.&LN:'1M4$L! A0#%     @ 3(:;4AB./Y=ID@  (TL$ !4
M ( !.C4  '1M,C$Q-#$Q,V0Q7V5X,BTQ+FAT;5!+ 0(4 Q0    ( $R&FU)
M21C-FPT  *Y!   6              "  =;'  !T;3(Q,30Q,3-D,5]E>#DY
<+3$N:'1M4$L%!@     &  8 B0$  *75      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
